Prescription ID | TCMF6736 |
Pinyin Name | Zi Shen Ning Shen Wan |
Chinese Name | 滋肾宁神丸 |
English Name | Zi Shen Ning Shen Pills |
Function Description | 眩晕, 耳鸣, 不寐, 怔忡, 健忘, 遗精 |
Indications | Spontaneous palpitation disorder, Involuntary ejaculation disorder, Tinnitus disorder, Vertigo disorder, Forgetfulness disorder, Insomnia disorder, Insomnia, Tinnitus, Dizziness |
Disease ICD-11 Category |
SA11 [Spontaneous palpitation disorder (TM1), 怔忡 (TM1)
]; SB09 [Involuntary ejaculation disorder (TM1), 遗精 (TM1) ]; SC75 [Tinnitus disorder (TM1), 耳鸣 (TM1) ]; SD22 [Vertigo disorder (TM1), 眩晕 (TM1) ]; SD23 [Forgetfulness disorder (TM1), 健忘 (TM1) ]; SD84 [Insomnia disorder (TM1), 不寐 (TM1) ]; 7A0Z [Insomnia disorders, unspecified, 失眠障碍,未特指的 ]; MC41 [Tinnitus, 耳鸣 ]; MB48 [Dizziness and giddiness, 头晕和眩晕 ]; |
Human Tissues Associated with Indication | Brain, Heart, Kidney |
Reference | CFDA |
Reference Book/link | http://samr.cfda.gov.cn/WS01/CL0001/ |
Component ID | Latin Name | Chinese Name | Component Quantity | Barcode |
---|---|---|---|---|
TCMH1966 | Rehmannia glutinosa | 熟地黄 | TCMH1966 | ITSAH4578-14 |
TCMH1845 | Dioscorea batatas | 山药 | TCMH1845 | |
TCMH1133 | Rosa laevigata | 金樱子 | TCMH1133 | ITSAJ4477-14 |
TCMH2052 | Ziziphus jujuba var. spinosa | 酸枣仁 | TCMH2052 | ITSAM943-14 |
TCMH1963 | Caulis polygoni multiflori | 首乌藤 | TCMH1963 | |
TCMH1597 | Ligustrum lucidum | 女贞子 | TCMH1597 | ITSAM2109-14 |
TCMH2149 | Cuscuta australis | 菟丝子 | TCMH2149 | ITSAP4209-14 |
TCMH1565 | Millettia speciosa champ | 牛大力 | TCMH1565 | |
TCMH606 | Wolfiporia cocos | 茯苓 | TCMH606 | GBPOL314-13 |
TCMH2610 | Concha margaritifera usta;Margarita | 珍珠母 | TCMH2610 | |
TCMH104 | Paeonia lactiflora | 白芍 | TCMH104 | ITSAH2416-14 |
TCMH407 | Salvia miltiorrhiza | 丹参 | TCMH407 | ITSAH2408-14 |
TCMH819 | Polygonum multiflorum | 何首乌 | TCMH819 | ITSAL419-14 |
TCMH967 | Polygonatum sibiricum | 黄精 | TCMH967 | ITSAH4762-14 |
TCMH2202 | Schisandra chinensis | 五味子 | TCMH2202 | ITSAM2867-14 |
TCMH2215 | Ficus simplicissima | 五指毛桃 | TCMH2215 |
Target ID | Gene Symbol | Target Name | Target Class | Uniprot ID |
---|---|---|---|---|
TCMT100 | TTR | Transthyretin | Unclassified | P02766 |
TCMT101 | PTPN1 | Protein-tyrosine phosphatase 1B | Hydrolase | P18031 |
TCMT102 | ACP1 | Low molecular weight phosphotyrosine protein phosphatase | Hydrolase | P24666 |
TCMT103 | PTPRF | Receptor-type tyrosine-protein phosphatase F (LAR) | Hydrolase | P10586 |
TCMT112 | ADORA3 | Adenosine A3 receptor | GPCR | P0DMS8 |
TCMT126 | TERT | Telomerase reverse transcriptase | Transferase | O14746 |
TCMT127 | PARP1 | Poly [ADP-ribose] polymerase-1 | Transferase | P09874 |
TCMT130 | ALOX5 | Arachidonate 5-lipoxygenase | Oxidoreductase | P09917 |
TCMT131 | ACHE | Acetylcholinesterase | Hydrolase | P22303 |
TCMT133 | CA1 | Carbonic anhydrase I | Lyase | P00915 |
TCMT134 | CA2 | Carbonic anhydrase II | Lyase | P00918 |
TCMT135 | CA14 | Carbonic anhydrase XIV | Lyase | Q9ULX7 |
TCMT136 | CA12 | Carbonic anhydrase XII | Lyase | O43570 |
TCMT137 | CA9 | Carbonic anhydrase IX | Lyase | Q16790 |
TCMT138 | CA7 | Carbonic anhydrase VII | Lyase | P43166 |
TCMT142 | CA4 | Carbonic anhydrase IV | Lyase | P22748 |
TCMT150 | RORC | Nuclear receptor ROR-gamma | Nuclear receptor | P51449 |
TCMT156 | CYP19A1 | Cytochrome P450 19A1 | Oxidoreductase | P11511 |
TCMT159 | TYR | Tyrosinase | Oxidoreductase | P14679 |
TCMT164 | PTGS1 | Cyclooxygenase-1 | Oxidoreductase | P23219 |
TCMT171 | PTPN6 | Protein-tyrosine phosphatase 1C | Hydrolase | P29350 |
TCMT174 | HSD11B1 | 11-beta-hydroxysteroid dehydrogenase 1 | Oxidoreductase | P28845 |
TCMT189 | DUSP3 | Dual specificity protein phosphatase 3 | Hydrolase | P51452 |
TCMT190 | PTPN2 | T-cell protein-tyrosine phosphatase | Hydrolase | P17706 |
TCMT206 | CYP2A6 | Cytochrome P450 2A6 | Oxidoreductase | P11509 |
TCMT210 | CES2 | Carboxylesterase 2 | Hydrolase | O00748 |
TCMT211 | CES1 | Acyl coenzyme A:cholesterol acyltransferase | Transferase | P23141 |
TCMT212 | SRC | Tyrosine-protein kinase SRC | Kinase | P12931 |
TCMT215 | CYP1A1 | Cytochrome P450 1A1 | Oxidoreductase | P04798 |
TCMT217 | CYP2C8 | Cytochrome P450 2C8 | Oxidoreductase | P10632 |
TCMT219 | CYP1A2 | Cytochrome P450 1A2 | Oxidoreductase | P05177 |
TCMT223 | AKR1B1 | Aldose reductase | Oxidoreductase | P15121 |
TCMT23 | ALPL | Alkaline phosphatase, tissue-nonspecific isozyme | Hydrolase | P05186 |
TCMT233 | PTPN11 | Protein-tyrosine phosphatase 2C | Hydrolase | Q06124 |
TCMT236 | ESR2 | Estrogen receptor beta | Nuclear receptor | Q92731 |
TCMT239 | PIM1 | Serine/threonine-protein kinase PIM1 | Kinase | P11309 |
TCMT247 | ADRA2A | Alpha-2a adrenergic receptor | GPCR | P08913 |
TCMT254 | CBR1 | Carbonyl reductase [NADPH] 1 | Oxidoreductase | P16152 |
TCMT257 | CYP1B1 | Cytochrome P450 1B1 | Oxidoreductase | Q16678 |
TCMT260 | FLT3 | Tyrosine-protein kinase receptor FLT3 | Kinase | P36888 |
TCMT261 | DAPK1 | Death-associated protein kinase 1 | Kinase | P53355 |
TCMT280 | AKR1B10 | Aldo-keto reductase family 1 member B10 | Oxidoreductase | O60218 |
TCMT295 | MMP1 | Matrix metalloproteinase-1 | Hydrolase | P03956 |
TCMT296 | ADORA1 | Adenosine A1 receptor | GPCR | P30542 |
TCMT297 | FABP4 | Fatty acid binding protein adipocyte | Unclassified | P15090 |
TCMT298 | FABP3 | Fatty acid binding protein muscle | Hydrolase | P05413 |
TCMT3 | ALOX15 | Arachidonate 15-lipoxygenase | Oxidoreductase | P16050 |
TCMT30 | PTGS2 | Cyclooxygenase-2 | Oxidoreductase | P35354 |
TCMT306 | MMP2 | Matrix metalloproteinase-2 | Hydrolase | P08253 |
TCMT307 | KCNH2 | HERG | Ion channel | Q12809 |
TCMT31 | CYP2C19 | Cytochrome P450 2C19 | Oxidoreductase | P33261 |
TCMT321 | MMP9 | Matrix metalloproteinase 9 | Hydrolase | P14780 |
TCMT322 | MMP13 | Matrix metalloproteinase 13 | Hydrolase | P45452 |
TCMT327 | TRPV1 | Vanilloid receptor | Ion channel | Q8NER1 |
TCMT329 | NQO2 | Quinone reductase 2 | Oxidoreductase | P16083 |
TCMT33 | CYP3A4 | Cytochrome P450 3A4 | Oxidoreductase | P08684 |
TCMT344 | AOX1 | Aldehyde oxidase | Oxidoreductase | Q06278 |
TCMT354 | AURKA | Serine/threonine-protein kinase Aurora-A | Kinase | O14965 |
TCMT359 | FYN | Tyrosine-protein kinase FYN | Kinase | P06241 |
TCMT369 | IGF1R | Insulin-like growth factor I receptor | Kinase | P08069 |
TCMT370 | KDR | Vascular endothelial growth factor receptor 2 | Kinase | P35968 |
TCMT374 | AURKB | Serine/threonine-protein kinase Aurora-B | Kinase | Q96GD4 |
TCMT377 | INSR | Insulin receptor | Kinase | P06213 |
TCMT388 | AXL | Tyrosine-protein kinase receptor UFO | Kinase | P30530 |
TCMT401 | MET | Hepatocyte growth factor receptor | Kinase | P08581 |
TCMT402 | ALK | ALK tyrosine kinase receptor | Kinase | Q9UM73 |
TCMT418 | EPHB4 | Ephrin type-B receptor 4 | Kinase | P54760 |
TCMT422 | CAMK2B | CaM kinase II beta | Kinase | Q13554 |
TCMT423 | EGFR | Epidermal growth factor receptor erbB1 | Kinase | P00533 |
TCMT436 | NUAK1 | NUAK family SNF1-like kinase 1 | Kinase | O60285 |
TCMT441 | PTK2 | Focal adhesion kinase 1 | Kinase | Q05397 |
TCMT445 | NEK2 | Serine/threonine-protein kinase NEK2 | Kinase | P51955 |
TCMT45 | APP | Beta amyloid A4 protein | Unclassified | P05067 |
TCMT457 | FLT4 | Vascular endothelial growth factor receptor 3 | Kinase | P35916 |
TCMT462 | NEK6 | Serine/threonine-protein kinase NEK6 | Kinase | Q9HC98 |
TCMT479 | AKT1 | Serine/threonine-protein kinase AKT | Kinase | P31749 |
TCMT484 | PLK1 | Serine/threonine-protein kinase PLK1 | Kinase | P53350 |
TCMT502 | TEK | Tyrosine-protein kinase TIE-2 | Kinase | Q02763 |
TCMT536 | PDGFRB | Platelet-derived growth factor receptor beta | Kinase | P09619 |
TCMT555 | HDAC6 | Histone deacetylase 6 | Hydrolase | Q9UBN7 |
TCMT557 | HDAC1 | Histone deacetylase 1 | Hydrolase | Q13547 |
TCMT560 | F10 | Coagulation factor X | Unclassified | P00742 |
TCMT563 | CDC25B | Dual specificity phosphatase Cdc25B | Hydrolase | P30305 |
TCMT591 | ESRRA | Estrogen-related receptor alpha | Nuclear receptor | P11474 |
TCMT592 | XDH | Xanthine dehydrogenase | Oxidoreductase | P47989 |
TCMT597 | SLC28A3 | Solute carrier family 28 member 3 | Transporter | Q9HAS3 |
TCMT613 | NR3C1 | Glucocorticoid receptor | Nuclear receptor | P04150 |
TCMT614 | EGLN1 | Egl nine homolog 1 | Oxidoreductase | Q9GZT9 |
TCMT626 | BRAF | Serine/threonine-protein kinase B-raf | Kinase | P15056 |
TCMT63 | PPARA | Peroxisome proliferator-activated receptor alpha | Nuclear receptor | Q07869 |
TCMT633 | SLC6A4 | Serotonin transporter | Transporter | P31645 |
TCMT634 | SLC6A2 | Norepinephrine transporter | Transporter | P23975 |
TCMT65 | HSD17B1 | Estradiol 17-beta-dehydrogenase 1 | Oxidoreductase | P14061 |
TCMT651 | DRD3 | Dopamine D3 receptor | GPCR | P35462 |
TCMT66 | HSD17B2 | Estradiol 17-beta-dehydrogenase 2 | Oxidoreductase | P37059 |
TCMT690 | HDAC3 | Histone deacetylase 3 | Hydrolase | O15379 |
TCMT709 | SLC28A2 | Sodium/nucleoside cotransporter 2 | Transporter | O43868 |
TCMT710 | SLC28A1 | Sodium/nucleoside cotransporter 1 | Transporter | O00337 |
TCMT721 | HSPA1A | Heat shock 70 kDa protein 1 | Unclassified | P0DMV8 |
TCMT729 | PIK3CA | PI3-kinase p110-alpha subunit | Transferase | P42336 |
TCMT730 | PIK3CB | PI3-kinase p110-beta subunit | Transferase | P42338 |
TCMT734 | MMP12 | Matrix metalloproteinase 12 | Hydrolase | P39900 |
TCMT739 | GPR35 | G-protein coupled receptor 35 | GPCR | Q9HC97 |
TCMT752 | CSNK2A1 | Casein kinase II alpha | Kinase | P68400 |
TCMT753 | SMAD3 | Mothers against decapentaplegic homolog 3 | Unclassified | P84022 |
TCMT755 | PLK4 | Serine/threonine-protein kinase PLK4 | Kinase | O00444 |
TCMT756 | MAP3K8 | Mitogen-activated protein kinase kinase kinase 8 | Kinase | P41279 |
TCMT771 | ATR | Serine-protein kinase ATR | Kinase | Q13535 |
TCMT784 | AVPR2 | Vasopressin V2 receptor | GPCR | P30518 |
TCMT785 | CXCR1 | Interleukin-8 receptor A | GPCR | P25024 |
TCMT786 | CCR4 | C-C chemokine receptor type 4 | GPCR | P51679 |
TCMT791 | PKN1 | Protein kinase N1 | Kinase | Q16512 |
TCMT793 | PYGL | Liver glycogen phosphorylase | Transferase | P06737 |
TCMT808 | FABP5 | Fatty acid binding protein epidermal | Unclassified | Q01469 |
TCMT809 | FABP2 | Fatty acid binding protein intestinal | Unclassified | P12104 |
TCMT81 | ALOX12 | Arachidonate 12-lipoxygenase | Oxidoreductase | P18054 |
TCMT810 | TLR2 | Toll-like receptor 2 | Unclassified | O60603 |
TCMT82 | ESR1 | Estrogen receptor alpha | Nuclear receptor | P03372 |
TCMT822 | FUT7 | Alpha-(1,3)-fucosyltransferase 7 | Transferase | Q11130 |
TCMT83 | CD38 | Lymphocyte differentiation antigen CD38 | Unclassified | P28907 |
TCMT860 | HDAC10 | Histone deacetylase 10 | Hydrolase | Q969S8 |
TCMT87 | CYP2C9 | Cytochrome P450 2C9 | Oxidoreductase | P11712 |
TCMT910 | ESRRB | Estrogen-related receptor beta | Nuclear receptor | O95718 |
Target ID | Target Name |
---|---|
TCMT1168 | Trichomonas vaginalis |
TCMT1170 | Enterobacter cloacae |
TCMT1175 | Human immunodeficiency virus |
TCMT1176 | Streptococcus pneumoniae |
TCMT1178 | Actinomyces viscosus |
TCMT1180 | Human herpesvirus 2 |
TCMT1181 | Mycobacterium tuberculosis H37Ra |
TCMT1182 | Streptococcus sanguinis |
TCMT1189 | Pseudomonas fluorescens |
TCMT1190 | Plasmodium falciparum (isolate FcB1 / Columbia) |
TCMT1191 | Bacillus megaterium |
TCMT1208 | Escherichia coli K12 |
TCMT1209 | Staphylococcus haemolyticus |
TCMT1212 | Verticillium dahliae |
TCMT1213 | Neisseria gonorrhoeae |
TCMT1214 | Enterococcus faecium |
TCMT1215 | Pseudomonas aeruginosa PAO1 |
TCMT1217 | Bacillus anthracis |
TCMT1218 | Staphylococcus aureus |
TCMT1222 | Plasmodium falciparum D6 |
TCMT1223 | Staphylococcus epidermidis |
TCMT1226 | Klebsiella pneumoniae |
TCMT1229 | Enterococcus faecalis |
TCMT1231 | Human herpesvirus 1 strain KOS |
TCMT1232 | Pseudomonas aeruginosa |
TCMT1236 | Mycobacterium bovis |
TCMT1243 | Aspergillus flavus |
TCMT1246 | Escherichia coli |
TCMT1247 | Human herpesvirus 1 |
TCMT1248 | Hepatitis C virus |
TCMT1250 | Vesicular stomatitis virus |
TCMT1251 | Candida albicans |
TCMT1253 | Penicillium chrysogenum |
TCMT1255 | Human immunodeficiency virus 1 |
TCMT1260 | Streptococcus agalactiae |
TCMT1284 | Penicillium expansum |
TCMT1286 | Bacillus cereus |
TCMT1294 | Human parainfluenza virus 3 |
TCMT1319 | Corynebacterium xerosis |
TCMT1322 | Streptococcus mitis |
TCMT1323 | Corynebacterium pseudodiphtheriticum |
TCMT1324 | Corynebacterium diphtheriae |
TCMT1346 | Helicobacter pylori |
TCMT1349 | Helicobacter pylori SS1 |
TCMT1361 | Neisseria meningitidis |
TCMT1382 | Plasmodium falciparum (isolate K1 / Thailand) |
TCMT1390 | Human herpesvirus 2 strain G |
TCMT1393 | Vibrio sp. |
TCMT1405 | Penicillium citrinum |
TCMT1410 | Listeria monocytogenes |
TCMT1412 | Salmonella typhimurium |
TCMT1438 | Plasmodium falciparum |
TCMT1439 | Mycobacterium smegmatis |
TCMT1442 | Leishmania donovani |
TCMT1443 | Leishmania amazonensis |
TCMT1447 | Respiratory syncytial virus |
TCMT1448 | Enterobacter aerogenes |
TCMT1449 | Influenza A virus |
TCMT1450 | Plasmodium falciparum 3D7 |
TCMT1454 | Bacillus subtilis |
TCMT1455 | Mycobacterium tuberculosis H37Rv |
TCMT1458 | Filobasidiella neoformans |
TCMT1462 | Streptococcus mutans |
TCMT1463 | Mycobacterium tuberculosis |
TCMT1464 | Hepatitis B virus |
TCMT1465 | Entamoeba histolytica |
GO Term | GO Name | Enriched Genes | Log10 Adjusted P-value |
---|---|---|---|
[BP] GO:0006629 | lipid metabolic process | ACHE, ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, APP, CBR1, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, CYP3A4, EGFR, ESR1, FABP3, FABP4, FUT7, HSD11B1, HSD17B1, HSD17B2, MET, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, TRPV1 | 15.6024 |
[BP] GO:0008152 | metabolic process | ACHE, ADORA1, AKR1B1, AKR1B10, ALK, ALOX12, ALOX15, ALOX5, ALPL, AOX1, APP, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, CYP3A4, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, FUT7, HSD11B1, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, NQO2, NR3C1, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTK2, PTPN1, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, TRPV1, TYR, XDH | 12.9036 |
[BP] GO:0042221 | response to chemical | ADRA2A, AKR1B1, ALOX15, ALPL, APP, AXL, CA2, CA9, CES1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD3, EGFR, ESR1, ESRRA, FABP3, FABP4, FLT3, HSD17B2, HSPA1A, IGF1R, INSR, KCNH2, KDR, MMP2, MMP9, NR3C1, PIK3CA, PPARA, PTGS2, RORC, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TERT, TRPV1, TYR | 12.0528 |
[BP] GO:0042127 | regulation of cell proliferation | ADORA1, ADORA3, ADRA2A, AKR1B1, ALK, ALOX12, APP, CDC25B, CSNK2A1, CYP1B1, DRD3, EGFR, ESR1, ESRRA, FABP3, FLT3, HSPA1A, IGF1R, INSR, KDR, MMP12, MMP2, MMP9, NUAK1, PIM1, PTGS1, PTGS2, PTK2, SLC6A4, SMAD3, SRC, TEK, TERT, XDH | 11.9172 |
[BP] GO:0065008 | regulation of biological quality | ACHE, ADORA1, ADRA2A, AKR1B1, ALOX12, ALOX15, APP, AURKB, AXL, CA12, CA2, CA7, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD3, EGFR, ESR1, F10, FABP3, FABP4, FLT3, GPR35, HSD11B1, HSD17B1, HSD17B2, HSPA1A, INSR, KCNH2, KDR, MET, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, PTK2, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TERT, TRPV1, XDH | 11.4478 |
[BP] GO:0010033 | response to organic substance | ADRA2A, AKR1B1, ALOX15, ALPL, APP, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD3, EGFR, ESR1, ESRRA, FABP3, FABP4, FLT3, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MMP2, NR3C1, PIK3CA, PPARA, PTGS2, RORC, SLC6A4, SMAD3, SRC, TEK, TRPV1, TYR | 11.1189 |
[BP] GO:0010647 | positive regulation of cell communication | ADORA1, ADRA2A, AKR1B1, ALK, ALOX15, APP, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD3, EGFR, F10, FLT3, GPR35, HSPA1A, INSR, KDR, MET, MMP12, MMP9, PIK3CA, PIK3CB, PTGS2, PTK2, PTPN1, SMAD3, SRC, TEK, TERT, XDH | 11.086 |
[BP] GO:0023056 | positive regulation of signaling | ADORA1, ADRA2A, AKR1B1, ALK, ALOX15, APP, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD3, EGFR, F10, FLT3, GPR35, HSPA1A, INSR, KDR, MET, MMP12, MMP9, PIK3CA, PIK3CB, PTGS2, PTK2, PTPN1, SMAD3, SRC, TEK, TERT, XDH | 11.0741 |
[BP] GO:0033559 | unsaturated fatty acid metabolic process | ALOX12, ALOX15, ALOX5, CBR1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, PTGS1, PTGS2 | 10.91 |
[BP] GO:0044237 | cellular metabolic process | ACHE, AKR1B1, AKR1B10, ALK, ALOX12, ALOX15, ALOX5, ALPL, AOX1, APP, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, CYP3A4, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KCNH2, KDR, MET, MMP1, MMP2, NQO2, NR3C1, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTK2, PTPN1, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, TYR, XDH | 10.9017 |
[BP] GO:0044281 | small molecule metabolic process | AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, AOX1, APP, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CES1, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, CYP3A4, FABP3, FUT7, HSPA1A, PIK3CA, PIM1, PPARA, PTGS1, PTGS2, TYR, XDH | 10.7181 |
[BP] GO:0048522 | positive regulation of cellular process | ACHE, ADORA1, ADRA2A, AKR1B1, ALK, ALOX12, ALOX15, APP, AURKB, AXL, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FLT3, GPR35, HSPA1A, IGF1R, INSR, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTK2, PTPN1, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, TRPV1, XDH | 10.6945 |
[BP] GO:1901700 | response to oxygen-containing compound | AKR1B1, ALPL, APP, AXL, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD3, EGFR, ESR1, ESRRA, FABP3, HSD17B2, IGF1R, INSR, MMP2, MMP9, NR3C1, PIK3CA, PPARA, PTGS2, RORC, SLC6A4, SRC, TEK, TRPV1, TYR | 10.6945 |
[BP] GO:0006690 | icosanoid metabolic process | ALOX12, ALOX15, ALOX5, CBR1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, PTGS1, PTGS2 | 10.6866 |
[BP] GO:0019369 | arachidonic acid metabolic process | ALOX12, ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, PTGS1, PTGS2 | 10.627 |
[BP] GO:0044255 | cellular lipid metabolic process | ACHE, AKR1B10, ALOX12, ALOX15, ALOX5, CBR1, CES1, CES2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, CYP3A4, EGFR, FABP3, FABP4, FUT7, MET, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2 | 10.0302 |
[BP] GO:0008202 | steroid metabolic process | AKR1B1, AKR1B10, APP, CES1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, CYP3A4, ESR1, HSD11B1, HSD17B1, HSD17B2 | 9.96138 |
[BP] GO:0009967 | positive regulation of signal transduction | ADORA1, ADRA2A, AKR1B1, ALK, ALOX15, APP, AXL, CSNK2A1, CYP1B1, DRD3, EGFR, F10, FLT3, GPR35, HSPA1A, INSR, KDR, MET, MMP12, MMP9, PIK3CA, PIK3CB, PTGS2, PTK2, PTPN1, SMAD3, SRC, TEK, TERT, XDH | 9.82732 |
[BP] GO:1902531 | regulation of intracellular signal transduction | ADORA1, ADRA2A, AKR1B1, ALK, ALOX15, APP, AURKB, AXL, CSNK2A1, CYP1B1, DRD3, DUSP3, EGFR, ESR1, F10, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NUAK1, PIK3CA, PIK3CB, PTGS2, PTK2, PTPN1, SRC, TEK, XDH | 9.42531 |
[BP] GO:0048518 | positive regulation of biological process | ACHE, ADORA1, ADRA2A, AKR1B1, ALK, ALOX12, ALOX15, APP, AURKB, AXL, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, GPR35, HSPA1A, IGF1R, INSR, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTK2, PTPN1, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, TRPV1, XDH | 9.30627 |
[BP] GO:0070887 | cellular response to chemical stimulus | ADRA2A, AKR1B1, ALOX15, ALPL, APP, AXL, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, FABP4, FLT3, HSPA1A, IGF1R, INSR, KCNH2, KDR, MMP2, MMP9, NR3C1, PIK3CA, PTGS2, RORC, SLC6A4, SMAD3, SRC, TERT, TRPV1 | 9.28513 |
[BP] GO:1902533 | positive regulation of intracellular signal transduction | ADORA1, ADRA2A, AKR1B1, ALK, ALOX15, APP, AXL, CYP1B1, EGFR, F10, FLT3, GPR35, HSPA1A, INSR, KDR, MET, PIK3CA, PIK3CB, PTGS2, PTK2, PTPN1, SRC, TEK, XDH | 9.15091 |
[BP] GO:0009719 | response to endogenous stimulus | ADRA2A, AKR1B1, ALPL, APP, CA2, CA9, CSNK2A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, IGF1R, INSR, MMP2, NR3C1, PPARA, PTGS2, SLC6A4, SMAD3, SRC, TEK, TRPV1 | 9.10003 |
[BP] GO:0006631 | fatty acid metabolic process | ALOX12, ALOX15, ALOX5, CBR1, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, FABP3, PPARA, PTGS1, PTGS2 | 8.9958 |
[BP] GO:0014070 | response to organic cyclic compound | ALPL, APP, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD3, EGFR, ESR1, ESRRA, FLT3, NR3C1, PTGS2, RORC, SLC6A4, SRC, TEK, TRPV1, TYR | 8.97821 |
[BP] GO:0050896 | response to stimulus | ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, ALK, ALOX15, ALPL, APP, AURKB, AXL, CA2, CA9, CES1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD3, EGFR, ESR1, ESRRA, F10, FABP3, FABP4, FLT3, HSD17B2, HSPA1A, IGF1R, INSR, KCNH2, KDR, MMP12, MMP2, MMP9, NR3C1, NUAK1, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, PTK2, PTPN1, RORC, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TERT, TRPV1, TYR | 8.97761 |
[BP] GO:1901568 | fatty acid derivative metabolic process | ALOX12, ALOX15, ALOX5, CBR1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, PTGS1, PTGS2 | 8.87186 |
[BP] GO:0009725 | response to hormone | ADRA2A, AKR1B1, ALPL, CA2, CA9, CSNK2A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, INSR, NR3C1, PPARA, PTGS2, SLC6A4, SRC, TEK, TRPV1 | 8.82098 |
[BP] GO:0032501 | multicellular organismal process | ADORA1, ADRA2A, AKR1B1, AKR1B10, ALK, ALOX12, ALOX15, ALOX5, ALPL, APP, AXL, CYP19A1, CYP1A2, CYP1B1, DRD3, DUSP3, EGFR, ESR1, ESRRB, F10, FABP4, HSD17B2, IGF1R, INSR, KCNH2, MET, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIM1, PPARA, PTGS2, RORC, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TRPV1, TYR | 8.61576 |
[BP] GO:0010941 | regulation of cell death | ADORA1, AKR1B1, ALK, ALOX12, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, ESR1, FLT3, HSPA1A, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTK2, PTPN1, SMAD3, SRC, TEK, TERT, TRPV1, XDH | 8.39761 |
[BP] GO:0043067 | regulation of programmed cell death | ADORA1, AKR1B1, ALK, ALOX12, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, ESR1, FLT3, HSPA1A, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PIM1, PTGS2, PTK2, PTPN1, SMAD3, SRC, TEK, TERT, TRPV1, XDH | 8.39761 |
[BP] GO:0048584 | positive regulation of response to stimulus | ADORA1, ADRA2A, AKR1B1, ALK, ALOX15, APP, AXL, CSNK2A1, CYP1B1, DRD3, EGFR, ESRRA, F10, FABP4, FLT3, GPR35, HSPA1A, INSR, KDR, MET, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PTGS2, PTK2, PTPN1, SMAD3, SRC, TEK, TERT, XDH | 8.30474 |
[BP] GO:0010646 | regulation of cell communication | ACHE, ADORA1, ADRA2A, AKR1B1, ALK, ALOX15, APP, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD3, DUSP3, EGFR, ESR1, ESR2, F10, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NUAK1, PIK3CA, PIK3CB, PTGS2, PTK2, PTPN1, SLC6A4, SMAD3, SRC, TEK, TERT, XDH | 8.30474 |
[BP] GO:0055114 | oxidation-reduction process | AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, AOX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, CYP3A4, HSD11B1, HSD17B1, HSD17B2, NQO2, PTGS1, PTGS2, TYR, XDH | 8.30474 |
[BP] GO:0044238 | primary metabolic process | ACHE, ADORA1, AKR1B1, AKR1B10, ALK, ALOX12, ALOX15, ALOX5, ALPL, AOX1, APP, AURKB, AXL, CBR1, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, CYP3A4, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, FUT7, HSD11B1, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTK2, PTPN1, RORC, SMAD3, SRC, TEK, TERT, TRPV1, TYR, XDH | 8.30474 |
[BP] GO:0001676 | long-chain fatty acid metabolic process | ALOX12, ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, PTGS1, PTGS2 | 8.24211 |
[BP] GO:0032879 | regulation of localization | ACHE, ADORA1, ADORA3, ADRA2A, ALOX12, ALOX15, APP, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD3, EGFR, F10, GPR35, HSPA1A, IGF1R, INSR, KCNH2, KDR, MET, MMP12, MMP9, PIK3CB, PPARA, PTGS2, PTK2, PTPN1, SLC6A4, SMAD3, SRC, TEK, TERT, TRPV1 | 8.1827 |
[BP] GO:0023051 | regulation of signaling | ACHE, ADORA1, ADRA2A, AKR1B1, ALK, ALOX15, APP, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD3, DUSP3, EGFR, ESR1, ESR2, F10, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NUAK1, PIK3CA, PIK3CB, PTGS2, PTK2, PTPN1, SLC6A4, SMAD3, SRC, TEK, TERT, XDH | 8.17202 |
[BP] GO:0071704 | organic substance metabolic process | ACHE, ADORA1, AKR1B1, AKR1B10, ALK, ALOX12, ALOX15, ALOX5, ALPL, AOX1, APP, AURKB, AXL, CBR1, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, CYP3A4, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, FUT7, HSD11B1, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTK2, PTPN1, RORC, SMAD3, SRC, TEK, TERT, TRPV1, TYR, XDH | 7.9211 |
[BP] GO:0046777 | protein autophosphorylation | ALK, AURKB, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, PIM1, PTK2, SRC, TEK | 7.85043 |
[BP] GO:0060548 | negative regulation of cell death | ADORA1, AKR1B1, ALOX12, AURKB, AXL, CSNK2A1, EGFR, HSPA1A, IGF1R, KDR, MET, MMP9, PIK3CA, PIM1, PPARA, PTGS2, PTK2, PTPN1, SMAD3, SRC, TEK, TERT | 7.85043 |
[BP] GO:0030335 | positive regulation of cell migration | ADRA2A, ALOX12, APP, EGFR, F10, IGF1R, INSR, KDR, MET, MMP9, PTGS2, PTK2, SMAD3, SRC, TEK, TERT | 7.81438 |
[BP] GO:0042981 | regulation of apoptotic process | ADORA1, AKR1B1, ALK, ALOX12, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, ESR1, FLT3, HSPA1A, IGF1R, KDR, MMP9, PIK3CA, PIK3CB, PIM1, PTGS2, PTK2, PTPN1, SMAD3, SRC, TEK, TERT, TRPV1, XDH | 7.81438 |
[BP] GO:0030334 | regulation of cell migration | ADORA1, ADORA3, ADRA2A, ALOX12, APP, CYP19A1, CYP1B1, EGFR, F10, IGF1R, INSR, KDR, MET, MMP9, PTGS2, PTK2, SMAD3, SRC, TEK, TERT | 7.78092 |
[BP] GO:0043069 | negative regulation of programmed cell death | ADORA1, AKR1B1, ALOX12, AURKB, AXL, CSNK2A1, EGFR, HSPA1A, IGF1R, KDR, MET, MMP9, PIK3CA, PIM1, PTGS2, PTK2, PTPN1, SMAD3, SRC, TEK, TERT | 7.76105 |
[BP] GO:0006805 | xenobiotic metabolic process | CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP3A4, NQO2, PTGS1, RORC | 7.76105 |
[BP] GO:2000147 | positive regulation of cell motility | ADRA2A, ALOX12, APP, EGFR, F10, IGF1R, INSR, KDR, MET, MMP9, PTGS2, PTK2, SMAD3, SRC, TEK, TERT | 7.62692 |
[BP] GO:0040012 | regulation of locomotion | ADORA1, ADORA3, ADRA2A, ALOX12, APP, CYP19A1, CYP1B1, DRD3, EGFR, F10, IGF1R, INSR, KDR, MET, MMP9, PTGS2, PTK2, SMAD3, SRC, TEK, TERT | 7.58006 |
[BP] GO:0051896 | regulation of protein kinase B signaling | AXL, DRD3, EGFR, F10, INSR, MET, PIK3CA, PIK3CB, PTK2, SRC, TEK, XDH | 7.55355 |
[BP] GO:0071310 | cellular response to organic substance | ADRA2A, AKR1B1, ALOX15, ALPL, APP, AXL, CYP1A1, CYP1B1, EGFR, ESR1, FABP4, FLT3, IGF1R, INSR, KDR, MMP2, NR3C1, PIK3CA, PTGS2, RORC, SLC6A4, SMAD3, SRC, TRPV1 | 7.48291 |
[BP] GO:0051272 | positive regulation of cellular component movement | ADRA2A, ALOX12, APP, EGFR, F10, IGF1R, INSR, KDR, MET, MMP9, PTGS2, PTK2, SMAD3, SRC, TEK, TERT | 7.47641 |
[BP] GO:0033993 | response to lipid | ALPL, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, HSD17B2, NR3C1, PTGS2, RORC, SLC6A4, SRC, TYR | 7.45514 |
[BP] GO:2000145 | regulation of cell motility | ADORA1, ADORA3, ADRA2A, ALOX12, APP, CYP19A1, CYP1B1, EGFR, F10, IGF1R, INSR, KDR, MET, MMP9, PTGS2, PTK2, SMAD3, SRC, TEK, TERT | 7.36153 |
[BP] GO:0042592 | homeostatic process | ADORA1, ADRA2A, AKR1B1, ALOX12, APP, AXL, CA12, CA2, CA7, DRD3, EGFR, ESR1, FABP3, FABP4, FLT3, GPR35, INSR, KCNH2, MET, PIK3CA, PIK3CB, SMAD3, SRC, TERT, TRPV1 | 7.31101 |
[BP] GO:0040017 | positive regulation of locomotion | ADRA2A, ALOX12, APP, EGFR, F10, IGF1R, INSR, KDR, MET, MMP9, PTGS2, PTK2, SMAD3, SRC, TEK, TERT | 7.29005 |
[BP] GO:0019220 | regulation of phosphate metabolic process | ADORA1, ADRA2A, ALK, ALOX15, APP, CDC25B, DRD3, DUSP3, EGFR, ESRRB, FABP3, FABP4, FLT3, IGF1R, INSR, KDR, MMP9, NUAK1, PIK3CA, PIK3CB, PPARA, PTGS2, PTK2, PTPN1, SMAD3, SRC, TEK, XDH | 7.2617 |
[BP] GO:0051174 | regulation of phosphorus metabolic process | ADORA1, ADRA2A, ALK, ALOX15, APP, CDC25B, DRD3, DUSP3, EGFR, ESRRB, FABP3, FABP4, FLT3, IGF1R, INSR, KDR, MMP9, NUAK1, PIK3CA, PIK3CB, PPARA, PTGS2, PTK2, PTPN1, SMAD3, SRC, TEK, XDH | 7.18734 |
[BP] GO:0007169 | transmembrane receptor protein tyrosine kinase signaling pathway | ALK, AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PTK2, PTPN1, SRC, TEK | 7.16694 |
[BP] GO:0043066 | negative regulation of apoptotic process | ADORA1, AKR1B1, ALOX12, AURKB, AXL, CSNK2A1, EGFR, HSPA1A, IGF1R, KDR, MMP9, PIK3CA, PIM1, PTGS2, PTK2, PTPN1, SMAD3, SRC, TEK, TERT | 7.12099 |
[BP] GO:0032502 | developmental process | ACHE, ADORA1, AKR1B1, ALK, ALOX15, ALPL, APP, AURKB, AXL, CA2, CA9, CBR1, CDC25B, CES1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, ESRRA, ESRRB, FABP4, FLT3, FUT7, HSD11B1, HSD17B2, INSR, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTK2, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, TYR | 7.07825 |
[BP] GO:0051173 | positive regulation of nitrogen compound metabolic process | ADORA1, ADRA2A, ALK, ALOX15, APP, AURKB, CDC25B, CSNK2A1, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NR3C1, PIK3CA, PIK3CB, PPARA, PTGS2, PTK2, PTPN1, RORC, SMAD3, SRC, TEK, TERT, TRPV1, XDH | 7.04672 |
[BP] GO:0018108 | peptidyl-tyrosine phosphorylation | ALK, AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, PTK2, SRC, TEK | 7.02856 |
[BP] GO:0051716 | cellular response to stimulus | ADRA2A, AKR1B1, ALOX15, ALPL, APP, AURKB, AXL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, FABP4, FLT3, HSPA1A, IGF1R, INSR, KCNH2, KDR, MMP2, MMP9, NR3C1, NUAK1, PIK3CA, PTGS2, PTPN1, RORC, SLC6A4, SMAD3, SRC, TERT, TRPV1 | 7.02477 |
[BP] GO:0048513 | animal organ development | ACHE, AXL, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, EGFR, ESR1, ESRRA, ESRRB, FLT3, HSD11B1, HSD17B2, INSR, KDR, PIK3CA, PPARA, PTK2, SMAD3, SRC, TEK, TYR | 7.00706 |
[BP] GO:0018212 | peptidyl-tyrosine modification | ALK, AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, PTK2, SRC, TEK | 6.97096 |
[BP] GO:0009893 | positive regulation of metabolic process | ADORA1, ADRA2A, ALK, ALOX15, APP, AURKB, CDC25B, CSNK2A1, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NR3C1, PIK3CA, PIK3CB, PPARA, PTGS2, PTK2, PTPN1, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, TRPV1, XDH | 6.92571 |
[BP] GO:0008284 | positive regulation of cell proliferation | ADRA2A, AKR1B1, ALOX12, CDC25B, CSNK2A1, DRD3, EGFR, ESR1, FLT3, IGF1R, INSR, KDR, MMP12, MMP2, MMP9, PIM1, PTGS2, PTK2, TEK, TERT | 6.91004 |
[BP] GO:0010562 | positive regulation of phosphorus metabolic process | ADORA1, ADRA2A, ALK, ALOX15, APP, CDC25B, EGFR, ESRRB, FABP3, FLT3, INSR, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTK2, PTPN1, SMAD3, SRC, TEK, XDH | 6.84948 |
[BP] GO:0045937 | positive regulation of phosphate metabolic process | ADORA1, ADRA2A, ALK, ALOX15, APP, CDC25B, EGFR, ESRRB, FABP3, FLT3, INSR, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTK2, PTPN1, SMAD3, SRC, TEK, XDH | 6.84948 |
[BP] GO:0051270 | regulation of cellular component movement | ADORA1, ADORA3, ADRA2A, ALOX12, APP, CYP19A1, CYP1B1, EGFR, F10, IGF1R, INSR, KDR, MET, MMP9, PTGS2, PTK2, SMAD3, SRC, TEK, TERT | 6.84924 |
[BP] GO:0015701 | bicarbonate transport | CA1, CA12, CA14, CA2, CA4, CA7, CA9 | 6.82436 |
[BP] GO:0010035 | response to inorganic substance | AKR1B1, ALOX15, APP, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, EGFR, FABP4, KDR, MMP9, PTGS2, SRC, TERT | 6.73554 |
[BP] GO:0051897 | positive regulation of protein kinase B signaling | AXL, EGFR, F10, INSR, MET, PIK3CA, PIK3CB, PTK2, SRC, TEK | 6.7106 |
[BP] GO:0031325 | positive regulation of cellular metabolic process | ADORA1, ADRA2A, ALK, ALOX15, APP, AURKB, CDC25B, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NR3C1, PIK3CA, PIK3CB, PPARA, PTGS2, PTK2, PTPN1, RORC, SMAD3, SRC, TEK, TERT, TRPV1, XDH | 6.65546 |
[BP] GO:0048583 | regulation of response to stimulus | ADORA1, ADRA2A, AKR1B1, ALK, ALOX12, ALOX15, APP, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, F10, FABP4, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP2, MMP9, NUAK1, PIK3CA, PIK3CB, PPARA, PTGS2, PTK2, PTPN1, SMAD3, SRC, TEK, TERT, XDH | 6.65005 |
[BP] GO:0008610 | lipid biosynthetic process | ACHE, AKR1B1, ALOX12, ALOX15, CES1, CSNK2A1, CYP19A1, CYP1A1, CYP3A4, HSD11B1, HSD17B1, HSD17B2, PIK3CA, PIK3CB, PTGS1, PTGS2 | 6.63564 |
[BP] GO:0010604 | positive regulation of macromolecule metabolic process | ADORA1, ADRA2A, ALK, ALOX15, APP, AURKB, CDC25B, CSNK2A1, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NR3C1, PIK3CA, PIK3CB, PPARA, PTGS2, PTK2, PTPN1, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, XDH | 6.61535 |
[BP] GO:0032787 | None | ALOX12, ALOX15, ALOX5, CBR1, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, FABP3, PPARA, PTGS1, PTGS2 | 6.55885 |
[BP] GO:0009966 | regulation of signal transduction | ADORA1, ADRA2A, AKR1B1, ALK, ALOX15, APP, AURKB, AXL, CSNK2A1, CYP1B1, DRD3, DUSP3, EGFR, ESR1, ESR2, F10, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NUAK1, PIK3CA, PIK3CB, PTGS2, PTK2, PTPN1, SMAD3, SRC, TEK, TERT, XDH | 6.5217 |
[BP] GO:0048878 | chemical homeostasis | ADRA2A, AKR1B1, ALOX12, APP, CA12, CA2, CA7, DRD3, EGFR, ESR1, FABP3, FABP4, GPR35, INSR, KCNH2, MET, PIK3CA, PIK3CB, SMAD3, TRPV1 | 6.49455 |
[BP] GO:0019748 | secondary metabolic process | AKR1B1, AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2A6, TYR | 6.41552 |
[BP] GO:0007167 | enzyme linked receptor protein signaling pathway | ALK, AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PTK2, PTPN1, SMAD3, SRC, TEK | 6.30886 |
[BP] GO:0071407 | cellular response to organic cyclic compound | ALPL, APP, CYP1A1, CYP1B1, EGFR, ESR1, FLT3, NR3C1, PTGS2, RORC, SLC6A4, SRC, TRPV1 | 6.2992 |
[BP] GO:0006796 | phosphate-containing compound metabolic process | ACHE, ALK, ALOX15, ALPL, APP, AURKB, AXL, CDC25B, CSNK2A1, DUSP3, EGFR, FLT3, HSPA1A, IGF1R, INSR, KCNH2, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, PTGS2, PTK2, PTPN1, SRC, TEK, XDH | 6.23798 |
[BP] GO:0048523 | negative regulation of cellular process | ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, ALOX12, APP, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GPR35, HSPA1A, IGF1R, KCNH2, KDR, MET, MMP12, MMP9, NR3C1, PIK3CA, PIM1, PPARA, PTGS2, PTK2, PTPN1, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, TRPV1, XDH | 6.21203 |
[BP] GO:0042327 | positive regulation of phosphorylation | ADORA1, ADRA2A, ALK, ALOX15, APP, CDC25B, EGFR, ESRRB, FLT3, INSR, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTK2, PTPN1, SRC, TEK, XDH | 6.1868 |
[BP] GO:0042445 | hormone metabolic process | ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD11B1, HSD17B1, HSD17B2 | 5.97455 |
[BP] GO:0042325 | regulation of phosphorylation | ADORA1, ADRA2A, ALK, ALOX15, APP, CDC25B, DUSP3, EGFR, ESRRB, FABP4, FLT3, IGF1R, INSR, KDR, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTK2, PTPN1, SRC, TEK, XDH | 5.89646 |
[BP] GO:0006793 | phosphorus metabolic process | ACHE, ALK, ALOX15, ALPL, APP, AURKB, AXL, CDC25B, CSNK2A1, DUSP3, EGFR, FLT3, HSPA1A, IGF1R, INSR, KCNH2, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, PTGS2, PTK2, PTPN1, SRC, TEK, XDH | 5.8367 |
[BP] GO:0006730 | one-carbon metabolic process | CA1, CA12, CA2, CA4, CA7, CA9 | 5.8194 |
[BP] GO:0006468 | protein phosphorylation | ALK, APP, AURKB, AXL, CDC25B, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KCNH2, KDR, MET, NUAK1, PIK3CA, PIM1, PTK2, SRC, TEK | 5.81494 |
[BP] GO:0001934 | positive regulation of protein phosphorylation | ADORA1, ADRA2A, ALK, ALOX15, APP, CDC25B, EGFR, FLT3, INSR, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTK2, PTPN1, SRC, TEK, XDH | 5.74423 |
[BP] GO:1901701 | cellular response to oxygen-containing compound | AKR1B1, APP, AXL, CYP1B1, EGFR, ESR1, IGF1R, INSR, MMP2, MMP9, NR3C1, PIK3CA, PTGS2, RORC, SLC6A4, SRC, TRPV1 | 5.65264 |
[BP] GO:0065009 | regulation of molecular function | ADORA1, ADORA3, ADRA2A, ALK, APP, AURKB, CDC25B, CSNK2A1, CYP1B1, DRD3, DUSP3, EGFR, ESR1, ESR2, FABP4, FLT3, GPR35, HSPA1A, IGF1R, INSR, MET, MMP9, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTK2, PTPN1, SMAD3, SRC, TEK, TERT, TRPV1, XDH | 5.60959 |
[BP] GO:0048856 | anatomical structure development | ACHE, ADORA1, AKR1B1, ALK, ALOX15, ALPL, APP, AXL, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, ESRRA, ESRRB, FLT3, HSD11B1, HSD17B2, INSR, KDR, MMP9, PIK3CA, PIM1, PPARA, PTGS2, PTK2, RORC, SMAD3, SRC, TEK, TYR | 5.52541 |
[BP] GO:0034754 | cellular hormone metabolic process | AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD17B1, HSD17B2 | 5.52541 |
[BP] GO:0051049 | regulation of transport | ACHE, ADORA1, ADRA2A, ALOX15, APP, AXL, CA2, CA7, CYP19A1, DRD3, EGFR, GPR35, HSPA1A, INSR, KCNH2, MMP12, MMP9, PIK3CB, PPARA, PTGS2, PTPN1, SLC6A4, SMAD3, SRC, TERT, TRPV1 | 5.47871 |
[BP] GO:0080134 | regulation of response to stress | ADORA1, ADRA2A, ALOX12, APP, CYP19A1, DUSP3, EGFR, ESR1, FABP4, HSPA1A, IGF1R, MET, MMP12, MMP2, NUAK1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, XDH | 5.47191 |
[BP] GO:0050790 | regulation of catalytic activity | ADORA1, ADORA3, ADRA2A, ALK, APP, AURKB, CDC25B, CSNK2A1, DRD3, DUSP3, EGFR, ESR1, FABP4, FLT3, HSPA1A, IGF1R, INSR, MMP9, NUAK1, PIK3CA, PIK3CB, PTGS2, PTK2, PTPN1, SMAD3, SRC, TEK, TERT, XDH | 5.43368 |
[BP] GO:0019373 | epoxygenase P450 pathway | CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19 | 5.42169 |
[BP] GO:0009628 | response to abiotic stimulus | ADORA1, AKR1B1, APP, AURKB, CA2, CYP1A1, DRD3, EGFR, HSPA1A, MMP2, PPARA, PTGS2, SLC6A4, SMAD3, SRC, TEK, TERT, TRPV1, TYR | 5.37989 |
[BP] GO:0043410 | positive regulation of MAPK cascade | ADORA1, ADRA2A, ALK, ALOX15, APP, EGFR, FLT3, INSR, KDR, PIK3CB, PTPN1, SRC, TEK, XDH | 5.3789 |
[BP] GO:0048585 | negative regulation of response to stimulus | ADORA1, ADRA2A, ALOX12, ALOX15, CYP19A1, DRD3, DUSP3, EGFR, ESR1, ESR2, HSPA1A, IGF1R, MET, MMP12, MMP9, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, XDH | 5.35762 |
[BP] GO:0048519 | negative regulation of biological process | ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, ALOX12, ALOX15, APP, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GPR35, HSPA1A, IGF1R, KCNH2, KDR, MET, MMP12, MMP9, NR3C1, PIK3CA, PIM1, PPARA, PTGS2, PTK2, PTPN1, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, TRPV1, XDH | 5.34164 |
[BP] GO:0001932 | regulation of protein phosphorylation | ADORA1, ADRA2A, ALK, ALOX15, APP, CDC25B, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTK2, PTPN1, SRC, TEK, XDH | 5.26614 |
[BP] GO:0019216 | regulation of lipid metabolic process | ADORA1, ADRA2A, CYP1A1, DRD3, FABP3, FLT3, PPARA, PTGS2, PTK2, RORC, SRC, TEK | 5.24266 |
[BP] GO:0017144 | drug metabolic process | ACHE, AKR1B1, AKR1B10, AOX1, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, CYP3A4, DRD3, EGFR, HSPA1A | 5.23103 |
[BP] GO:0043408 | regulation of MAPK cascade | ADORA1, ADRA2A, ALK, ALOX15, APP, DUSP3, EGFR, FLT3, IGF1R, INSR, KDR, PIK3CB, PTPN1, SRC, TEK, XDH | 5.19813 |
[BP] GO:0016310 | phosphorylation | ALK, APP, AURKB, AXL, CDC25B, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KCNH2, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, PTK2, SRC, TEK | 5.18717 |
[BP] GO:0038083 | peptidyl-tyrosine autophosphorylation | EGFR, IGF1R, INSR, KDR, PTK2, SRC | 5.18627 |
[BP] GO:0010648 | negative regulation of cell communication | ACHE, ADORA1, ADRA2A, DRD3, DUSP3, EGFR, ESR1, ESR2, GPR35, HSPA1A, IGF1R, MET, MMP12, MMP9, PTGS2, PTPN1, SLC6A4, SMAD3, SRC, TERT, XDH | 5.1292 |
[BP] GO:0030522 | intracellular receptor signaling pathway | ESR1, ESR2, ESRRA, ESRRB, NR3C1, PIM1, PPARA, RORC, SRC | 5.11946 |
[BP] GO:0023057 | negative regulation of signaling | ACHE, ADORA1, ADRA2A, DRD3, DUSP3, EGFR, ESR1, ESR2, GPR35, HSPA1A, IGF1R, MET, MMP12, MMP9, PTGS2, PTPN1, SLC6A4, SMAD3, SRC, TERT, XDH | 5.1122 |
[BP] GO:0051239 | regulation of multicellular organismal process | ADORA1, ADORA3, ADRA2A, ALOX12, APP, AXL, CA2, CYP1B1, DRD3, EGFR, ESR1, ESRRA, ESRRB, GPR35, HSPA1A, INSR, KCNH2, KDR, MET, MMP12, MMP9, PIK3CA, PIM1, PTGS2, PTK2, SLC6A4, SMAD3, SRC, TEK, TERT, TRPV1, XDH | 5.10602 |
[BP] GO:0042493 | response to drug | AKR1B1, AXL, CA9, CYP1A1, CYP1B1, DRD3, EGFR, FABP3, KCNH2, KDR, NR3C1, PTGS2, SLC6A2, SLC6A4, SRC, TRPV1 | 5.07724 |
[BP] GO:0097267 | omega-hydroxylase P450 pathway | CYP1A1, CYP1A2, CYP1B1, CYP2C19 | 5.06647 |
[BP] GO:0009056 | catabolic process | ACHE, ADORA1, AKR1B10, AOX1, AURKB, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, CYP3A4, FABP3, FABP4, FUT7, HSPA1A, MMP1, MMP12, MMP2, MMP9, PIK3CB, SRC, XDH | 5.02429 |
[BP] GO:0043549 | regulation of kinase activity | ADORA1, ADRA2A, ALK, APP, CDC25B, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, PIK3CA, PIK3CB, PTK2, PTPN1, SRC, TEK | 5.01126 |
[BP] GO:0043401 | steroid hormone mediated signaling pathway | ESR1, ESR2, ESRRA, ESRRB, NR3C1, PPARA, RORC, SRC | 4.99114 |
[BP] GO:0051050 | positive regulation of transport | ACHE, ADORA1, ADRA2A, APP, AXL, CA2, CYP19A1, DRD3, EGFR, INSR, KCNH2, MMP12, PTGS2, SLC6A4, SMAD3, SRC, TERT, TRPV1 | 4.97517 |
[BP] GO:0019752 | carboxylic acid metabolic process | ALOX12, ALOX15, ALOX5, CBR1, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, FABP3, PIM1, PPARA, PTGS1, PTGS2, TYR | 4.94669 |
[BP] GO:0010243 | response to organonitrogen compound | AKR1B1, APP, DRD3, EGFR, FABP3, FLT3, IGF1R, INSR, MMP2, PPARA, PTGS2, SLC6A4, SRC, TEK, TRPV1, TYR | 4.90413 |
[BP] GO:0001505 | regulation of neurotransmitter levels | ACHE, CYP1B1, DRD3, EGFR, INSR, PTGS2, SLC6A2, SLC6A4, SMAD3, TRPV1 | 4.82526 |
[BP] GO:0051247 | positive regulation of protein metabolic process | ADORA1, ADRA2A, ALK, ALOX15, APP, CDC25B, CSNK2A1, EGFR, ESR1, FLT3, HSPA1A, INSR, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTK2, PTPN1, SMAD3, SRC, TEK, XDH | 4.77686 |
[BP] GO:0001666 | response to hypoxia | ADORA1, CYP1A1, MMP2, PPARA, PTGS2, SLC6A4, SMAD3, SRC, TEK, TERT | 4.77026 |
[BP] GO:0071495 | cellular response to endogenous stimulus | ADRA2A, AKR1B1, APP, EGFR, ESR1, FLT3, IGF1R, INSR, MMP2, NR3C1, PTGS2, SLC6A4, SMAD3, SRC, TRPV1 | 4.74608 |
[BP] GO:0042738 | exogenous drug catabolic process | CYP1A2, CYP2A6, CYP2C19, CYP3A4 | 4.74608 |
[BP] GO:0031399 | regulation of protein modification process | ADORA1, ADRA2A, ALK, ALOX15, APP, CDC25B, DUSP3, EGFR, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MMP9, NUAK1, PIK3CA, PIK3CB, PTGS2, PTK2, PTPN1, SRC, TEK, XDH | 4.72305 |
[BP] GO:1901615 | organic hydroxy compound metabolic process | AKR1B1, AKR1B10, ALOX12, ALOX15, APP, CES1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD3, TYR | 4.72024 |
[BP] GO:0045859 | regulation of protein kinase activity | ADORA1, ADRA2A, ALK, APP, CDC25B, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, PIK3CA, PIK3CB, PTK2, PTPN1, SRC | 4.72024 |
[BP] GO:0051338 | regulation of transferase activity | ADORA1, ADRA2A, ALK, APP, AURKB, CDC25B, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, PIK3CA, PIK3CB, PTK2, PTPN1, SRC, TEK | 4.68466 |
[BP] GO:0036293 | response to decreased oxygen levels | ADORA1, CYP1A1, MMP2, PPARA, PTGS2, SLC6A4, SMAD3, SRC, TEK, TERT | 4.67307 |
[BP] GO:0043405 | regulation of MAP kinase activity | ADORA1, ADRA2A, ALK, DUSP3, EGFR, FLT3, IGF1R, INSR, PIK3CB, PTPN1, SRC | 4.66999 |
[BP] GO:0010817 | regulation of hormone levels | ACHE, ADORA1, ADRA2A, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, EGFR, ESR1, HSD11B1, HSD17B1, HSD17B2 | 4.64158 |
[BP] GO:0042446 | hormone biosynthetic process | AKR1B1, CYP19A1, CYP3A4, HSD11B1, HSD17B1, HSD17B2 | 4.59413 |
[BP] GO:0032270 | positive regulation of cellular protein metabolic process | ADORA1, ADRA2A, ALK, ALOX15, APP, CDC25B, EGFR, ESR1, FLT3, HSPA1A, INSR, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTK2, PTPN1, SMAD3, SRC, TEK, XDH | 4.59106 |
[BP] GO:1901698 | response to nitrogen compound | AKR1B1, APP, DRD3, EGFR, FABP3, FLT3, IGF1R, INSR, MMP2, PPARA, PTGS2, SLC6A4, SRC, TEK, TRPV1, TYR | 4.50976 |
[BP] GO:0044092 | negative regulation of molecular function | ADORA3, ADRA2A, APP, AURKB, CSNK2A1, CYP1B1, DRD3, DUSP3, ESR1, FABP4, GPR35, IGF1R, MET, MMP9, PIM1, PPARA, PTGS2, PTPN1, SRC | 4.50115 |
[BP] GO:0035690 | cellular response to drug | AKR1B1, AXL, CYP1B1, EGFR, KCNH2, KDR, NR3C1, PTGS2, SRC, TRPV1 | 4.47065 |
[BP] GO:0006721 | terpenoid metabolic process | AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP3A4, EGFR | 4.41372 |
[BP] GO:0043436 | oxoacid metabolic process | ALOX12, ALOX15, ALOX5, CBR1, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, FABP3, PIM1, PPARA, PTGS1, PTGS2, TYR | 4.40697 |
[BP] GO:0070482 | response to oxygen levels | ADORA1, CYP1A1, MMP2, PPARA, PTGS2, SLC6A4, SMAD3, SRC, TEK, TERT | 4.35462 |
[BP] GO:0009987 | cellular process | ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, AKR1B10, ALK, ALOX12, ALOX15, ALOX5, ALPL, AOX1, APP, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, CYP3A4, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, FUT7, GPR35, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, NQO2, NR3C1, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTK2, PTPN1, RORC, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TERT, TRPV1, TYR, XDH | 4.35267 |
[BP] GO:0045787 | positive regulation of cell cycle | APP, AURKB, CDC25B, CYP1A1, DRD3, DUSP3, EGFR, INSR, SLC6A4, SRC, TERT | 4.32097 |
[BP] GO:0006950 | response to stress | ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, APP, AXL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, EGFR, HSPA1A, MMP2, MMP9, NUAK1, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, PTK2, PTPN1, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TERT, TRPV1 | 4.32026 |
[BP] GO:0006082 | organic acid metabolic process | ALOX12, ALOX15, ALOX5, CBR1, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, FABP3, PIM1, PPARA, PTGS1, PTGS2, TYR | 4.31064 |
[BP] GO:0033674 | positive regulation of kinase activity | ADORA1, ADRA2A, ALK, CDC25B, EGFR, FLT3, INSR, PIK3CA, PIK3CB, PTK2, PTPN1, SRC, TEK | 4.30935 |
[BP] GO:0046456 | icosanoid biosynthetic process | ALOX12, ALOX15, ALOX5, PTGS1, PTGS2 | 4.29651 |
[BP] GO:0031401 | positive regulation of protein modification process | ADORA1, ADRA2A, ALK, ALOX15, APP, CDC25B, EGFR, FLT3, INSR, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTK2, PTPN1, SRC, TEK, XDH | 4.29651 |
[BP] GO:0044093 | positive regulation of molecular function | ADORA1, ADRA2A, ALK, APP, AURKB, CDC25B, EGFR, ESR1, ESR2, FLT3, HSPA1A, INSR, MET, MMP9, PIK3CA, PIK3CB, PTK2, PTPN1, SMAD3, SRC, TEK, TERT, XDH | 4.27475 |
[BP] GO:0009755 | hormone-mediated signaling pathway | ESR1, ESR2, ESRRA, ESRRB, NR3C1, PPARA, RORC, SRC | 4.26055 |
[BP] GO:0019372 | lipoxygenase pathway | ALOX12, ALOX15, ALOX5, PTGS2 | 4.25751 |
[BP] GO:0048010 | vascular endothelial growth factor receptor signaling pathway | AXL, KDR, PIK3CA, PIK3CB, PTK2, SRC | 4.20918 |
[BP] GO:0032844 | regulation of homeostatic process | ADORA1, ADRA2A, AURKB, CA2, CA7, DRD3, EGFR, KDR, PIK3CB, PTGS2, SRC, TRPV1 | 4.15222 |
[BP] GO:1904407 | positive regulation of nitric oxide metabolic process | EGFR, INSR, PTGS2, SMAD3, TRPV1 | 4.08557 |
[BP] GO:0045429 | positive regulation of nitric oxide biosynthetic process | EGFR, INSR, PTGS2, SMAD3, TRPV1 | 4.08557 |
[BP] GO:0048661 | positive regulation of smooth muscle cell proliferation | AKR1B1, EGFR, MMP2, MMP9, PTGS2, TERT | 4.0777 |
[BP] GO:0045834 | positive regulation of lipid metabolic process | FABP3, FLT3, PPARA, PTGS2, PTK2, SRC, TEK | 4.04667 |
[BP] GO:0010038 | response to metal ion | ALOX15, APP, CA2, CYP1A1, CYP1A2, EGFR, FABP4, MMP9, PTGS2, TERT | 4.03279 |
[BP] GO:0051347 | positive regulation of transferase activity | ADORA1, ADRA2A, ALK, AURKB, CDC25B, EGFR, FLT3, INSR, PIK3CA, PIK3CB, PTK2, PTPN1, SRC, TEK | 4.02279 |
[BP] GO:0006720 | isoprenoid metabolic process | AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP3A4, EGFR | 4.00567 |
[BP] GO:0051240 | positive regulation of multicellular organismal process | ADRA2A, ALOX12, APP, AXL, CA2, CYP1B1, DRD3, EGFR, ESRRB, HSPA1A, KDR, MET, MMP12, MMP9, PIM1, PTGS2, SMAD3, SRC, TEK, TERT, TRPV1 | 4.00233 |
[BP] GO:1903727 | positive regulation of phospholipid metabolic process | FABP3, FLT3, PTK2, SRC, TEK | 3.99448 |
[BP] GO:0006694 | steroid biosynthetic process | AKR1B1, CES1, CYP19A1, CYP3A4, HSD11B1, HSD17B1, HSD17B2 | 3.98855 |
[BP] GO:0043085 | positive regulation of catalytic activity | ADORA1, ADRA2A, ALK, APP, AURKB, CDC25B, EGFR, ESR1, FLT3, HSPA1A, INSR, PIK3CA, PIK3CB, PTK2, PTPN1, SMAD3, SRC, TEK, TERT, XDH | 3.90605 |
[BP] GO:0015711 | organic anion transport | CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD3, FABP3, PPARA, TRPV1 | 3.86448 |
[BP] GO:2001300 | lipoxin metabolic process | ALOX12, ALOX15, ALOX5 | 3.84386 |
[BP] GO:0016098 | monoterpenoid metabolic process | CYP1A2, CYP2C19, CYP3A4 | 3.84386 |
[BP] GO:0045860 | positive regulation of protein kinase activity | ADORA1, ADRA2A, ALK, CDC25B, EGFR, FLT3, INSR, PIK3CA, PIK3CB, PTK2, PTPN1, SRC | 3.82442 |
[BP] GO:0043406 | positive regulation of MAP kinase activity | ADORA1, ADRA2A, ALK, EGFR, FLT3, INSR, PIK3CB, PTPN1, SRC | 3.79077 |
[BP] GO:0006979 | response to oxidative stress | AKR1B1, APP, AXL, CYP1B1, EGFR, HSPA1A, MMP9, PTGS1, PTGS2, SRC | 3.77318 |
[BP] GO:1901652 | response to peptide | AKR1B1, APP, FABP3, IGF1R, INSR, PPARA, PTGS2, SRC, TEK, TRPV1 | 3.71169 |
[BP] GO:0043271 | negative regulation of ion transport | ADORA1, ADRA2A, DRD3, GPR35, KCNH2, MMP9, PTGS2 | 3.68464 |
[BP] GO:2000379 | positive regulation of reactive oxygen species metabolic process | EGFR, INSR, PTGS2, SMAD3, TRPV1, XDH | 3.68421 |
[BP] GO:0045931 | positive regulation of mitotic cell cycle | APP, CDC25B, CYP1A1, DRD3, DUSP3, INSR, TERT | 3.62751 |
[BP] GO:1903428 | positive regulation of reactive oxygen species biosynthetic process | EGFR, INSR, PTGS2, SMAD3, TRPV1 | 3.60797 |
[BP] GO:0008210 | estrogen metabolic process | CYP19A1, CYP1B1, HSD17B1, HSD17B2 | 3.55974 |
[BP] GO:0071248 | cellular response to metal ion | ALOX15, CYP1A1, CYP1A2, EGFR, FABP4, MMP9, PTGS2 | 3.55763 |
[BP] GO:0048511 | rhythmic process | AXL, CSNK2A1, DRD3, EGFR, ESR1, PPARA, RORC, SLC6A4, SRC | 3.55763 |
[BP] GO:0051893 | regulation of focal adhesion assembly | KDR, PTK2, SMAD3, SRC, TEK | 3.54058 |
[BP] GO:0090109 | regulation of cell-substrate junction assembly | KDR, PTK2, SMAD3, SRC, TEK | 3.54058 |
[BP] GO:0040008 | regulation of growth | ALOX12, APP, CSNK2A1, DRD3, EGFR, ESR2, HSPA1A, INSR, PIK3CA, PIM1, PTK2, SLC6A4, SMAD3 | 3.54058 |
[BP] GO:0008283 | cell proliferation | ACHE, ALK, AURKB, CYP1A1, EGFR, ESR1, FLT3, MET, PIK3CB, PIM1, SRC, TEK, TYR | 3.53518 |
[BP] GO:0009891 | positive regulation of biosynthetic process | APP, AURKB, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, IGF1R, INSR, KDR, MET, MMP12, NR3C1, PPARA, PTGS2, RORC, SMAD3, SRC, TERT, TRPV1 | 3.49288 |
[BP] GO:1901564 | organonitrogen compound metabolic process | ACHE, AKR1B1, ALK, ALPL, AOX1, APP, AURKB, AXL, CDC25B, CSNK2A1, CYP1A1, CYP1A2, CYP3A4, DRD3, DUSP3, EGFR, ESR1, F10, FLT3, FUT7, HSPA1A, IGF1R, INSR, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIK3CA, PIM1, PPARA, PTGS2, PTK2, PTPN1, SMAD3, SRC, TEK, TYR, XDH | 3.47616 |
[BP] GO:0003018 | None | ADORA1, ADRA2A, EGFR, PTGS2, SLC6A4, SRC, TEK | 3.44496 |
[BP] GO:0050801 | ion homeostasis | APP, CA12, CA2, CA7, DRD3, EGFR, ESR1, FABP3, GPR35, KCNH2, PIK3CB, SMAD3, TRPV1 | 3.44496 |
[BP] GO:0030155 | regulation of cell adhesion | ALOX12, ALOX15, CYP1B1, DUSP3, KDR, NUAK1, PIK3CA, PIK3CB, PPARA, PTK2, SMAD3, SRC, TEK | 3.44496 |
[BP] GO:1903391 | regulation of adherens junction organization | KDR, PTK2, SMAD3, SRC, TEK | 3.44496 |
[BP] GO:0045428 | regulation of nitric oxide biosynthetic process | EGFR, INSR, PTGS2, SMAD3, TRPV1 | 3.44496 |
[BP] GO:0050793 | regulation of developmental process | ALOX12, APP, AXL, CA2, CYP1B1, DRD3, EGFR, ESR1, ESRRA, ESRRB, INSR, KDR, NUAK1, PIK3CA, PIM1, PPARA, PTGS2, PTK2, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, TRPV1, XDH | 3.4368 |
[BP] GO:0032101 | regulation of response to external stimulus | ADORA1, ALOX12, CYP19A1, DRD3, EGFR, ESR1, FABP4, KDR, MET, MMP12, PPARA, PTGS2, SMAD3, TEK | 3.41736 |
[BP] GO:0051701 | interaction with host | AXL, EGFR, HSPA1A, INSR, MET, SMAD3, SRC | 3.40426 |
[BP] GO:0031347 | regulation of defense response | ADORA1, CYP19A1, EGFR, ESR1, FABP4, HSPA1A, MMP12, MMP2, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK | 3.39548 |
[BP] GO:0001952 | regulation of cell-matrix adhesion | KDR, PIK3CB, PTK2, SMAD3, SRC, TEK | 3.39351 |
[BP] GO:0050804 | modulation of chemical synaptic transmission | ACHE, ADORA1, APP, CA2, CA7, DRD3, EGFR, PTGS2, SLC6A4 | 3.39351 |
[BP] GO:0099177 | regulation of trans-synaptic signaling | ACHE, ADORA1, APP, CA2, CA7, DRD3, EGFR, PTGS2, SLC6A4 | 3.39351 |
[BP] GO:0006367 | transcription initiation from RNA polymerase II promoter | ESR1, ESR2, ESRRA, ESRRB, NR3C1, PPARA, RORC | 3.37858 |
[BP] GO:1901617 | organic hydroxy compound biosynthetic process | AKR1B1, ALOX12, ALOX15, CES1, CYP19A1, CYP3A4, TYR | 3.34641 |
[BP] GO:0009892 | negative regulation of metabolic process | ADORA1, ADRA2A, APP, AURKB, CSNK2A1, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, FABP4, HSPA1A, IGF1R, KDR, MET, MMP12, MMP9, NR3C1, PIK3CA, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TERT, TRPV1, XDH | 3.34374 |
[BP] GO:0007166 | cell surface receptor signaling pathway | ADORA1, ADORA3, ALK, APP, AXL, CA1, CSNK2A1, EGFR, FLT3, GPR35, IGF1R, INSR, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PTK2, PTPN1, SMAD3, SRC, TEK, TRPV1 | 3.34301 |
[BP] GO:0009894 | regulation of catabolic process | ADORA1, ADRA2A, CSNK2A1, EGFR, ESRRB, HSPA1A, INSR, KDR, MET, PIK3CA, PIK3CB, PPARA, PTK2, PTPN1, SMAD3 | 3.34301 |
[BP] GO:0071417 | cellular response to organonitrogen compound | AKR1B1, APP, EGFR, IGF1R, INSR, MMP2, PTGS2, SLC6A4, SRC, TRPV1 | 3.31209 |
[BP] GO:0034614 | cellular response to reactive oxygen species | AKR1B1, AXL, CYP1B1, EGFR, MMP9, SRC | 3.29754 |
[BP] GO:0006636 | unsaturated fatty acid biosynthetic process | ALOX12, ALOX15, PTGS1, PTGS2 | 3.28813 |
[BP] GO:0032147 | activation of protein kinase activity | ADORA1, ADRA2A, ALK, EGFR, INSR, PIK3CA, PIK3CB, PTPN1, SRC | 3.26848 |
[BP] GO:0060255 | regulation of macromolecule metabolic process | ACHE, ADORA1, ADORA3, ADRA2A, ALK, ALOX15, APP, AURKB, CA9, CDC25B, CSNK2A1, CYP1A2, CYP1B1, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NR3C1, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTK2, PTPN1, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, TRPV1, XDH | 3.26413 |
[BP] GO:0009636 | response to toxic substance | AKR1B1, ALPL, AXL, CES1, CYP1A1, CYP1B1, DRD3, KDR, SLC6A4, SRC | 3.25496 |
[BP] GO:0009968 | negative regulation of signal transduction | ADRA2A, DRD3, DUSP3, EGFR, ESR1, ESR2, HSPA1A, IGF1R, MET, MMP12, MMP9, PTGS2, PTPN1, SMAD3, SRC, TERT, XDH | 3.25174 |
[BP] GO:2000377 | regulation of reactive oxygen species metabolic process | CYP1B1, EGFR, INSR, PTGS2, SMAD3, TRPV1, XDH | 3.25033 |
[BP] GO:0003006 | developmental process involved in reproduction | ALPL, AXL, CDC25B, CYP19A1, EGFR, ESR1, ESRRB, HSD17B2, INSR, PTGS2, PTK2, SRC | 3.23865 |
[BP] GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity | FLT3, PTK2, SRC, TEK | 3.23865 |
[BP] GO:0007165 | signal transduction | ADORA1, ADORA3, ADRA2A, AKR1B1, ALK, APP, AXL, CA1, CA2, CSNK2A1, CYP1B1, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPR35, IGF1R, INSR, KCNH2, KDR, MET, MMP2, MMP9, NR3C1, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTK2, PTPN1, RORC, SMAD3, SRC, TEK, TRPV1 | 3.23769 |
[BP] GO:0071900 | regulation of protein serine/threonine kinase activity | ADORA1, ADRA2A, ALK, DUSP3, EGFR, FLT3, IGF1R, INSR, PIK3CB, PTPN1, SRC | 3.20975 |
[BP] GO:0071241 | cellular response to inorganic substance | ALOX15, CYP1A1, CYP1A2, EGFR, FABP4, MMP9, PTGS2 | 3.20975 |
[BP] GO:0001101 | response to acid chemical | AKR1B1, EGFR, FABP3, HSD17B2, KDR, MMP2, PTGS2, SLC6A4, SRC | 3.19969 |
[BP] GO:0001503 | ossification | ALOX15, ALPL, EGFR, MMP2, MMP9, TEK | 3.18594 |
[BP] GO:0071363 | cellular response to growth factor stimulus | APP, EGFR, INSR, KDR, NR3C1, SMAD3, SRC, TRPV1 | 3.17502 |
[BP] GO:0001775 | cell activation | ADRA2A, ALOX5, APP, AXL, EGFR, FLT3, FUT7, HSPA1A, MMP9, PIK3CA, PIK3CB, RORC, SMAD3, SRC, TRPV1 | 3.13179 |
[BP] GO:0031328 | positive regulation of cellular biosynthetic process | APP, AURKB, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, IGF1R, INSR, MET, MMP12, NR3C1, PPARA, PTGS2, RORC, SMAD3, SRC, TERT, TRPV1 | 3.12047 |
[BP] GO:1902532 | negative regulation of intracellular signal transduction | DRD3, DUSP3, ESR1, HSPA1A, IGF1R, MET, MMP9, PTGS2, PTPN1, SRC, XDH | 3.11097 |
[BP] GO:0009611 | response to wounding | ACHE, ADORA3, ALOX15, CYP1A1, EGFR, PPARA, SMAD3 | 3.11058 |
[BP] GO:0048871 | multicellular organismal homeostasis | ADORA1, AKR1B1, ALOX12, MET, PIK3CA, TRPV1 | 3.11058 |
[BP] GO:0019222 | regulation of metabolic process | ACHE, ADORA1, ADORA3, ADRA2A, ALK, ALOX15, APP, AURKB, CA9, CDC25B, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NR3C1, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTK2, PTPN1, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, TRPV1, XDH | 3.10776 |
[BP] GO:0022414 | reproductive process | AKR1B1, ALPL, APP, AXL, CDC25B, CYP19A1, CYP1A1, EGFR, ESR1, ESRRB, HSD17B2, INSR, MMP2, MMP9, PTGS2, PTK2, SLC6A4, SRC | 3.10582 |
[BP] GO:0090218 | positive regulation of lipid kinase activity | FLT3, PTK2, SRC, TEK | 3.09706 |
[BP] GO:0010907 | None | ESRRB, INSR, PPARA, SRC | 3.09706 |
[BP] GO:0019371 | None | CBR1, PTGS1, PTGS2 | 3.0734 |
[BP] GO:0050806 | positive regulation of synaptic transmission | ADORA1, APP, CA2, CA7, EGFR, PTGS2 | 3.06295 |
[BP] GO:1901699 | cellular response to nitrogen compound | AKR1B1, APP, EGFR, IGF1R, INSR, MMP2, PTGS2, SLC6A4, SRC, TRPV1 | 3.06231 |
[BP] GO:0001525 | angiogenesis | CYP1B1, KDR, MMP2, PIK3CA, PIK3CB, PTGS2, PTK2, TEK | 3.06176 |
[BP] GO:0032268 | regulation of cellular protein metabolic process | ADORA1, ADRA2A, ALK, ALOX15, APP, CDC25B, CSNK2A1, DUSP3, EGFR, ESR1, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MMP9, NUAK1, PIK3CA, PIK3CB, PTGS2, PTK2, PTPN1, SMAD3, SRC, TEK, XDH | 3.04129 |
[BP] GO:1903725 | regulation of phospholipid metabolic process | FABP3, FLT3, PTK2, SRC, TEK | 3.03318 |
[BP] GO:0032355 | response to estradiol | CYP1A2, EGFR, ESR1, ESRRA, PTGS2, SLC6A4 | 3.01367 |
[BP] GO:0010810 | regulation of cell-substrate adhesion | ALOX15, KDR, PIK3CB, PTK2, SMAD3, SRC, TEK | 3.00225 |
[BP] GO:0035556 | intracellular signal transduction | ADRA2A, AKR1B1, ALK, AXL, CYP1B1, DRD3, EGFR, IGF1R, INSR, KCNH2, KDR, MET, NUAK1, PIK3CA, PIK3CB, PTK2, PTPN1, SRC, TEK | 3.00225 |
[BP] GO:0010634 | positive regulation of epithelial cell migration | KDR, MET, MMP9, PTGS2, SRC, TEK | 2.998 |
[BP] GO:0098771 | inorganic ion homeostasis | APP, CA12, CA2, CA7, DRD3, EGFR, ESR1, GPR35, KCNH2, PIK3CB, SMAD3, TRPV1 | 2.99144 |
[BP] GO:0044283 | None | AKR1B1, ALOX12, ALOX15, ALOX5, CES1, CYP19A1, CYP1A1, CYP3A4, PTGS1, PTGS2 | 2.98419 |
[BP] GO:0018193 | peptidyl-amino acid modification | ALK, AURKB, AXL, CSNK2A1, EGFR, F10, FLT3, IGF1R, INSR, KDR, MET, PTK2, SRC, TEK | 2.95469 |
[BP] GO:0071902 | positive regulation of protein serine/threonine kinase activity | ADORA1, ADRA2A, ALK, EGFR, FLT3, INSR, PIK3CB, PTPN1, SRC | 2.94957 |
[BP] GO:0048660 | regulation of smooth muscle cell proliferation | AKR1B1, EGFR, MMP2, MMP9, PTGS2, TERT | 2.94626 |
[BP] GO:0006820 | anion transport | CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD3, FABP3, PPARA, TRPV1 | 2.94142 |
[BP] GO:0009896 | positive regulation of catabolic process | ADRA2A, CSNK2A1, ESRRB, HSPA1A, INSR, KDR, PIK3CB, PPARA, PTK2, PTPN1 | 2.94142 |
[BP] GO:0007584 | response to nutrient | ALPL, CYP1A1, EGFR, PTGS2, SLC6A4, TRPV1, TYR | 2.94142 |
[BP] GO:0034599 | cellular response to oxidative stress | AKR1B1, AXL, CYP1B1, EGFR, HSPA1A, MMP9, SRC | 2.93416 |
[BP] GO:0009115 | None | AOX1, XDH | 2.93416 |
[BP] GO:2001301 | lipoxin biosynthetic process | ALOX12, ALOX15 | 2.93416 |
[BP] GO:2001302 | lipoxin A4 metabolic process | ALOX12, ALOX15 | 2.93416 |
[BP] GO:2001303 | lipoxin A4 biosynthetic process | ALOX12, ALOX15 | 2.93416 |
[BP] GO:0016042 | lipid catabolic process | ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FABP4 | 2.93228 |
[BP] GO:1900182 | positive regulation of protein localization to nucleus | APP, EGFR, PTGS2, SMAD3, SRC, TERT | 2.92827 |
[BP] GO:0046683 | response to organophosphorus | APP, PTGS2, SLC6A4, TEK, TRPV1, TYR | 2.92827 |
[BP] GO:0007346 | regulation of mitotic cell cycle | APP, AURKB, CDC25B, CYP1A1, DRD3, DUSP3, EGFR, HSPA1A, INSR, PIM1, SMAD3, TERT | 2.90631 |
[BP] GO:0051171 | regulation of nitrogen compound metabolic process | ADORA1, ADORA3, ADRA2A, ALK, ALOX15, APP, AURKB, CA9, CDC25B, CSNK2A1, CYP1B1, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NR3C1, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTK2, PTPN1, RORC, SMAD3, SRC, TEK, TERT, TRPV1, XDH | 2.89719 |
[BP] GO:0070372 | regulation of ERK1 and ERK2 cascade | ALOX15, APP, DUSP3, EGFR, KDR, PTPN1, SRC, TEK | 2.89297 |
[BP] GO:0006703 | estrogen biosynthetic process | CYP19A1, HSD17B1, HSD17B2 | 2.88846 |
[BP] GO:0080090 | regulation of primary metabolic process | ADORA1, ADORA3, ADRA2A, ALK, ALOX15, APP, AURKB, CA9, CDC25B, CSNK2A1, CYP1A1, CYP1B1, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NR3C1, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTK2, PTPN1, RORC, SMAD3, SRC, TEK, TERT, TRPV1, XDH | 2.87496 |
[BP] GO:0045935 | positive regulation of nucleobase-containing compound metabolic process | APP, AURKB, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, HSPA1A, IGF1R, INSR, MET, MMP12, NR3C1, PPARA, PTPN1, RORC, SMAD3, SRC, TERT | 2.8549 |
[BP] GO:1901570 | None | ALOX12, ALOX15, ALOX5, PTGS1, PTGS2 | 2.85452 |
[BP] GO:0070848 | response to growth factor | APP, EGFR, INSR, KDR, NR3C1, SMAD3, SRC, TRPV1 | 2.84316 |
[BP] GO:0031323 | regulation of cellular metabolic process | ACHE, ADORA1, ADORA3, ADRA2A, ALK, ALOX15, APP, AURKB, CA9, CDC25B, CSNK2A1, CYP1B1, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NR3C1, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTK2, PTPN1, RORC, SMAD3, SRC, TEK, TERT, TRPV1, XDH | 2.83553 |
[BP] GO:0048869 | cellular developmental process | ACHE, ALK, ALPL, APP, AXL, CBR1, CDC25B, CES1, CYP1A1, EGFR, ESR1, ESRRB, FABP4, FLT3, FUT7, KDR, MET, MMP2, MMP9, PTGS2, PTK2, RORC, SMAD3, SRC, TEK, TERT | 2.8294 |
[BP] GO:0051726 | regulation of cell cycle | APP, AURKB, CDC25B, CSNK2A1, CYP1A1, DRD3, DUSP3, EGFR, HSPA1A, INSR, PIM1, PTGS2, SLC6A4, SMAD3, SRC, TERT | 2.81663 |
[BP] GO:0033273 | response to vitamin | ALPL, CYP1A1, EGFR, PTGS2, TYR | 2.81135 |
[BP] GO:1903426 | None | EGFR, INSR, PTGS2, SMAD3, TRPV1 | 2.81135 |
[BP] GO:1901888 | regulation of cell junction assembly | KDR, PTK2, SMAD3, SRC, TEK | 2.81135 |
[BP] GO:0006352 | DNA-templated transcription, initiation | ESR1, ESR2, ESRRA, ESRRB, NR3C1, PPARA, RORC | 2.81092 |
[BP] GO:0003013 | None | ADORA1, ADRA2A, EGFR, PTGS2, SLC6A4, SRC, TEK | 2.81092 |
[BP] GO:0043393 | regulation of protein binding | APP, AURKB, MET, MMP9, PPARA, SRC, TERT | 2.81092 |
[BP] GO:0031324 | negative regulation of cellular metabolic process | ADRA2A, APP, AURKB, CSNK2A1, DRD3, DUSP3, ESR1, ESR2, ESRRA, FABP4, HSPA1A, IGF1R, MET, MMP12, MMP9, NR3C1, PIK3CA, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TERT, TRPV1, XDH | 2.81092 |
[BP] GO:0060065 | uterus development | CYP19A1, ESR1, SRC | 2.80536 |
[BP] GO:0051130 | positive regulation of cellular component organization | ALOX15, APP, AURKB, AXL, DRD3, ESR1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP9, SMAD3, SRC, TEK | 2.80536 |
[BP] GO:1904063 | None | ADRA2A, DRD3, GPR35, KCNH2, MMP9 | 2.79459 |
[BP] GO:2000021 | regulation of ion homeostasis | ADORA1, CA2, CA7, DRD3, KDR, SRC, TRPV1 | 2.77661 |
[BP] GO:0042058 | None | ADORA1, ADRA2A, APP, EGFR, MMP9 | 2.72234 |
[BP] GO:0043551 | regulation of phosphatidylinositol 3-kinase activity | FLT3, PTK2, SRC, TEK | 2.71411 |
[BP] GO:0051047 | None | ACHE, ADORA1, CYP19A1, DRD3, EGFR, MMP12, SLC6A4, SRC, TRPV1 | 2.71411 |
[BP] GO:0051172 | None | ADRA2A, APP, AURKB, CSNK2A1, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, FABP4, HSPA1A, IGF1R, MMP12, MMP9, NR3C1, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TERT, TRPV1, XDH | 2.69965 |
[BP] GO:0010632 | regulation of epithelial cell migration | KDR, MET, MMP9, PTGS2, PTK2, SRC, TEK | 2.69088 |
[BP] GO:0014074 | response to purine-containing compound | APP, PTGS2, SLC6A4, TEK, TRPV1, TYR | 2.6796 |
[BP] GO:0051246 | regulation of protein metabolic process | ADORA1, ADRA2A, ALK, ALOX15, APP, CDC25B, CSNK2A1, DUSP3, EGFR, ESR1, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MMP9, NUAK1, PIK3CA, PIK3CB, PTGS2, PTK2, PTPN1, SMAD3, SRC, TEK, XDH | 2.66903 |
[BP] GO:0050727 | regulation of inflammatory response | ADORA1, CYP19A1, EGFR, ESR1, FABP4, PPARA, PTGS2, SMAD3, TEK | 2.66866 |
[BP] GO:0048545 | response to steroid hormone | ALPL, CA2, EGFR, FLT3, NR3C1, PTGS2, SRC | 2.64594 |
[BP] GO:2000811 | negative regulation of anoikis | PIK3CA, PTK2, SRC | 2.64174 |
[BP] GO:0030540 | female genitalia development | AXL, CYP19A1, ESR1 | 2.64174 |
[BP] GO:0070920 | None | EGFR, ESR1, TERT | 2.64174 |
[BP] GO:0032225 | None | DRD3, PTGS2, SLC6A4 | 2.64174 |
[BP] GO:0008217 | None | ADORA1, DRD3, PPARA, PTGS1, PTGS2, SMAD3 | 2.64127 |
[BP] GO:0031331 | positive regulation of cellular catabolic process | ADRA2A, ESRRB, HSPA1A, INSR, KDR, PIK3CB, PPARA, PTK2, PTPN1 | 2.61788 |
[BP] GO:0016477 | cell migration | AXL, CYP1B1, EGFR, FUT7, KDR, MMP1, MMP12, MMP9, PIK3CA, PIK3CB, PTK2, SRC, TEK | 2.60054 |
[BP] GO:0030198 | extracellular matrix organization | APP, CYP1B1, KDR, MMP1, MMP12, MMP2, MMP9, PTK2 | 2.57849 |
[BP] GO:0010557 | positive regulation of macromolecule biosynthetic process | APP, AURKB, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, IGF1R, INSR, KDR, MET, MMP12, NR3C1, PPARA, RORC, SMAD3, SRC, TERT | 2.57653 |
[BP] GO:0032846 | positive regulation of homeostatic process | AURKB, CA2, CA7, DRD3, EGFR, PIK3CB, PTGS2 | 2.57291 |
[BP] GO:0043062 | extracellular structure organization | APP, CYP1B1, KDR, MMP1, MMP12, MMP2, MMP9, PTK2 | 2.57291 |
[BP] GO:0043269 | regulation of ion transport | ADORA1, ADRA2A, APP, CA2, CA7, DRD3, GPR35, KCNH2, MMP9, PTGS2, SLC6A4 | 2.57291 |
[BP] GO:0045766 | positive regulation of angiogenesis | ALOX12, CYP1B1, KDR, PTGS2, TEK, TERT | 2.57041 |
[BP] GO:0034766 | None | ADRA2A, DRD3, GPR35, KCNH2, MMP9 | 2.56483 |
[BP] GO:0031960 | response to corticosteroid | ALPL, EGFR, FLT3, NR3C1, PTGS2, SRC | 2.55703 |
[BP] GO:0046486 | glycerolipid metabolic process | ACHE, ALOX15, CSNK2A1, EGFR, FABP3, FABP4, MET, PIK3CA, PIK3CB | 2.55378 |
[BP] GO:2001243 | negative regulation of intrinsic apoptotic signaling pathway | HSPA1A, MMP9, PTGS2, PTPN1, SRC | 2.54623 |
[BP] GO:0010638 | positive regulation of organelle organization | ALOX15, AURKB, DRD3, HSPA1A, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK | 2.53852 |
[BP] GO:0006928 | movement of cell or subcellular component | ADRA2A, ALOX12, APP, AXL, CYP1B1, EGFR, FUT7, KDR, MMP1, MMP12, MMP9, PIK3CA, PIK3CB, PTGS2, PTK2, SRC, TEK | 2.53852 |
[BP] GO:0002682 | regulation of immune system process | ADORA1, ALOX15, APP, AXL, CA2, CYP19A1, DUSP3, ESR1, ESRRA, HSPA1A, MMP12, MMP2, PIK3CA, PIK3CB, PTK2, PTPN1, SMAD3, SRC | 2.53852 |
[BP] GO:0010906 | None | ESRRB, INSR, PPARA, RORC, SRC | 2.53852 |
[BP] GO:0046110 | None | AOX1, XDH | 2.53852 |
[BP] GO:0032849 | positive regulation of cellular pH reduction | CA2, CA7 | 2.53852 |
[BP] GO:0032227 | negative regulation of synaptic transmission, dopaminergic | PTGS2, SLC6A4 | 2.53852 |
[BP] GO:0050730 | None | ADORA1, ADRA2A, APP, EGFR, FLT3, PTPN1, SRC | 2.536 |
[BP] GO:0014066 | regulation of phosphatidylinositol 3-kinase signaling | EGFR, FLT3, KDR, PTK2, TEK | 2.51975 |
[BP] GO:1901184 | None | ADORA1, ADRA2A, APP, EGFR, MMP9 | 2.47845 |
[BP] GO:0044057 | None | ADORA1, ADORA3, ADRA2A, DRD3, EGFR, GPR35, KCNH2, PTGS2, SMAD3, TRPV1 | 2.47363 |
[BP] GO:0022900 | electron transport chain | AKR1B1, AOX1, CYP19A1, CYP1A2, NQO2, XDH | 2.47363 |
[BP] GO:0055080 | cation homeostasis | APP, CA2, CA7, DRD3, EGFR, ESR1, GPR35, KCNH2, PIK3CB, SMAD3, TRPV1 | 2.47363 |
[BP] GO:0034763 | None | ADRA2A, DRD3, GPR35, KCNH2, MMP9 | 2.46307 |
[BP] GO:0051828 | entry into other organism involved in symbiotic interaction | AXL, EGFR, HSPA1A, MET, SRC | 2.44677 |
[BP] GO:0051806 | entry into cell of other organism involved in symbiotic interaction | AXL, EGFR, HSPA1A, MET, SRC | 2.44677 |
[BP] GO:0030260 | entry into host cell | AXL, EGFR, HSPA1A, MET, SRC | 2.44677 |
[BP] GO:0044409 | entry into host | AXL, EGFR, HSPA1A, MET, SRC | 2.44677 |
[BP] GO:0010676 | None | ESRRB, INSR, PPARA, SRC | 2.44566 |
[BP] GO:0043550 | regulation of lipid kinase activity | FLT3, PTK2, SRC, TEK | 2.44566 |
[BP] GO:0072593 | reactive oxygen species metabolic process | ALOX12, CYP1A1, CYP1A2, CYP1B1, EGFR | 2.42958 |
[BP] GO:0048732 | gland development | CSNK2A1, CYP19A1, EGFR, INSR, PIK3CA, SMAD3, TYR | 2.42506 |
[BP] GO:0030258 | lipid modification | ALOX12, CYP1A1, CYP3A4, EGFR, MET, PIK3CA, PIK3CB | 2.41489 |
[BP] GO:0010605 | negative regulation of macromolecule metabolic process | APP, AURKB, CSNK2A1, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, FABP4, HSPA1A, IGF1R, KDR, MMP12, MMP9, NR3C1, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TERT, TRPV1, XDH | 2.4145 |
[BP] GO:0009991 | response to extracellular stimulus | ALPL, AXL, CYP1A1, EGFR, PTGS2, SLC6A4, SRC, TRPV1, TYR | 2.36889 |
[BP] GO:0080135 | regulation of cellular response to stress | APP, DUSP3, EGFR, HSPA1A, IGF1R, MET, NUAK1, PTGS2, PTPN1, TERT, XDH | 2.36341 |
[BP] GO:0031348 | negative regulation of defense response | ADORA1, CYP19A1, MMP12, PPARA, SMAD3, TEK | 2.3619 |
[BP] GO:0044236 | multicellular organism metabolic process | MMP1, MMP12, MMP2, MMP9, TRPV1 | 2.3596 |
[BP] GO:0006954 | inflammatory response | ADORA1, ADORA3, ALOX15, AXL, PIK3CA, PIK3CB, PTGS1, PTGS2, TRPV1 | 2.35018 |
[BP] GO:0040011 | locomotion | AXL, CYP1B1, EGFR, FUT7, KDR, MET, MMP1, MMP12, MMP9, PIK3CA, PIK3CB, PTK2, SRC, TEK | 2.34955 |
[BP] GO:0051128 | regulation of cellular component organization | ALOX12, ALOX15, APP, AURKB, AXL, CSNK2A1, DRD3, EGFR, ESR1, ESR2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP9, PIK3CB, PTK2, PTPN1, SMAD3, SRC, TEK | 2.34046 |
[BP] GO:2000026 | regulation of multicellular organismal development | ALOX12, APP, AXL, CA2, CYP1B1, DRD3, EGFR, ESR1, ESRRA, INSR, KDR, PIM1, PTGS2, PTK2, SLC6A4, SMAD3, SRC, TEK, TERT, XDH | 2.34046 |
[BP] GO:0046686 | response to cadmium ion | CYP1A2, EGFR, MMP9, TERT | 2.33464 |
[BP] GO:0071498 | cellular response to fluid shear stress | CA2, PTGS2, SRC | 2.33464 |
[BP] GO:0000302 | response to reactive oxygen species | AKR1B1, AXL, CYP1B1, EGFR, MMP9, SRC | 2.32854 |
[BP] GO:1904018 | positive regulation of vasculature development | ALOX12, CYP1B1, KDR, PTGS2, TEK, TERT | 2.31597 |
[BP] GO:0051098 | regulation of binding | APP, AURKB, MET, MMP9, PPARA, SMAD3, SRC, TERT | 2.31298 |
[BP] GO:0030168 | platelet activation | ADRA2A, AXL, PIK3CA, PIK3CB, SRC | 2.29467 |
[BP] GO:0045596 | None | APP, DRD3, EGFR, ESRRB, PPARA, PTK2, SLC6A4, SMAD3, TERT, TRPV1, XDH | 2.29002 |
[BP] GO:0000122 | None | AURKB, DRD3, ESR1, ESR2, ESRRA, HSPA1A, MMP12, NR3C1, PPARA, RORC, SMAD3, TRPV1 | 2.28995 |
[BP] GO:0043542 | endothelial cell migration | CYP1B1, KDR, PIK3CA, PTK2 | 2.28995 |
[BP] GO:1901654 | None | AKR1B1, CA9, CSNK2A1, EGFR, NR3C1, SRC | 2.28995 |
[BP] GO:1904707 | positive regulation of vascular smooth muscle cell proliferation | MMP2, MMP9, TERT | 2.28995 |
[BP] GO:0030520 | intracellular estrogen receptor signaling pathway | ESR1, ESR2, SRC | 2.28995 |
[BP] GO:0006145 | None | AOX1, XDH | 2.28995 |
[BP] GO:0032847 | regulation of cellular pH reduction | CA2, CA7 | 2.28995 |
[BP] GO:0018894 | dibenzo-p-dioxin metabolic process | CYP1A1, CYP1A2 | 2.28995 |
[BP] GO:0007173 | epidermal growth factor receptor signaling pathway | EGFR, PIK3CA, PTK2, SRC | 2.26671 |
[BP] GO:0048870 | cell motility | AXL, CYP1B1, EGFR, FUT7, KDR, MMP1, MMP12, MMP9, PIK3CA, PIK3CB, PTK2, SRC, TEK | 2.26356 |
[BP] GO:0065007 | biological regulation | ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, ALK, ALOX12, ALOX15, APP, AURKB, AXL, CA1, CA12, CA2, CA7, CA9, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, GPR35, HSD11B1, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTK2, PTPN1, RORC, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TERT, TRPV1, XDH | 2.2418 |
[BP] GO:0042737 | drug catabolic process | ACHE, CYP1A2, CYP2A6, CYP2C19, CYP3A4 | 2.24031 |
[BP] GO:0009895 | negative regulation of catabolic process | ADORA1, ADRA2A, EGFR, MET, PIK3CA, PPARA, SMAD3 | 2.23989 |
[BP] GO:2000209 | regulation of anoikis | PIK3CA, PTK2, SRC | 2.23989 |
[BP] GO:0009404 | toxin metabolic process | CYP1A1, CYP1A2, CYP1B1 | 2.23989 |
[BP] GO:0051254 | None | APP, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, HSPA1A, INSR, MET, MMP12, NR3C1, PPARA, RORC, SMAD3, SRC, TERT | 2.23637 |
[BP] GO:0050728 | negative regulation of inflammatory response | ADORA1, CYP19A1, PPARA, SMAD3, TEK | 2.22727 |
[BP] GO:0071396 | cellular response to lipid | AXL, EGFR, ESR1, FLT3, NR3C1, RORC, SLC6A4, SRC | 2.2272 |
[BP] GO:0009888 | tissue development | ALOX15, ALPL, CYP1B1, INSR, KDR, PIK3CA, PPARA, PTGS2, RORC, SMAD3 | 2.2204 |
[BP] GO:0051894 | None | KDR, SMAD3, TEK | 2.18995 |
[BP] GO:0061900 | None | APP, EGFR, TRPV1 | 2.18995 |
[BP] GO:1903409 | reactive oxygen species biosynthetic process | CYP1A1, CYP1A2, CYP1B1 | 2.18995 |
[BP] GO:0048608 | reproductive structure development | AXL, CYP19A1, ESR1, HSD17B2, INSR, PTK2, SRC | 2.17833 |
[BP] GO:0090087 | None | ACHE, ADORA1, ADRA2A, APP, CA2, DRD3, EGFR, MMP12, PTGS2, PTPN1, SMAD3, SRC | 2.17415 |
[BP] GO:0050890 | None | ADORA1, APP, DRD3, EGFR, INSR, PTGS2, SLC6A4 | 2.16329 |
[BP] GO:0050805 | negative regulation of synaptic transmission | ACHE, ADORA1, PTGS2, SLC6A4 | 2.14985 |
[BP] GO:0090068 | positive regulation of cell cycle process | APP, AURKB, CDC25B, CYP1A1, DRD3, INSR, TERT | 2.14649 |
[BP] GO:0010675 | None | ESRRB, INSR, PPARA, RORC, SRC | 2.13766 |
[BP] GO:0030574 | collagen catabolic process | MMP1, MMP12, MMP2, MMP9 | 2.12645 |
[BP] GO:0008285 | negative regulation of cell proliferation | ADORA1, ADORA3, APP, CYP1B1, FABP3, HSPA1A, PTGS2, SLC6A4, SMAD3, TERT, XDH | 2.1127 |
[BP] GO:0043434 | None | FABP3, INSR, PPARA, PTGS2, SRC, TEK, TRPV1 | 2.11269 |
[BP] GO:0010628 | positive regulation of gene expression | APP, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, HSPA1A, INSR, MET, MMP12, NR3C1, PIK3CB, PPARA, RORC, SLC6A4, SMAD3, SRC, TERT | 2.11269 |
[BP] GO:0014068 | positive regulation of phosphatidylinositol 3-kinase signaling | FLT3, KDR, PTK2, TEK | 2.10885 |
[BP] GO:0032102 | negative regulation of response to external stimulus | ADORA1, ALOX12, CYP19A1, DRD3, PPARA, SMAD3, TEK | 2.10885 |
[BP] GO:0051122 | hepoxilin biosynthetic process | ALOX12, ALOX15 | 2.10885 |
[BP] GO:0051121 | hepoxilin metabolic process | ALOX12, ALOX15 | 2.10885 |
[BP] GO:0006706 | steroid catabolic process | CYP19A1, CYP1A2, CYP3A4 | 2.10885 |
[BP] GO:1903393 | None | KDR, SMAD3, TEK | 2.10885 |
[BP] GO:0006693 | None | CES2, PTGS1, PTGS2 | 2.10885 |
[BP] GO:0006692 | None | CES2, PTGS1, PTGS2 | 2.10885 |
[BP] GO:0097746 | None | ADORA1, ADRA2A, EGFR, PTGS2, SLC6A4 | 2.10523 |
[BP] GO:0035296 | None | ADORA1, ADRA2A, EGFR, PTGS2, SLC6A4 | 2.10523 |
[BP] GO:0070374 | positive regulation of ERK1 and ERK2 cascade | ALOX15, APP, EGFR, KDR, SRC, TEK | 2.09414 |
[BP] GO:0002009 | morphogenesis of an epithelium | CA2, CA9, EGFR, ESR1, MET, SMAD3, SRC | 2.08979 |
[BP] GO:0003008 | None | ADORA1, ADRA2A, AKR1B1, APP, CYP1B1, DRD3, EGFR, INSR, KCNH2, PIK3CA, PTGS2, SLC6A4, SRC, TEK, TRPV1, TYR | 2.08658 |
[BP] GO:0044248 | cellular catabolic process | ACHE, AKR1B10, AOX1, AURKB, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, CYP3A4, FABP3, FABP4, HSPA1A, PIK3CB, SRC, XDH | 2.0853 |
[BP] GO:0051241 | negative regulation of multicellular organismal process | ADORA1, ALOX12, APP, AXL, DRD3, EGFR, GPR35, PTGS2, PTK2, SLC6A4, SMAD3, TEK, TERT, XDH | 2.08028 |
[BP] GO:0045913 | None | ESRRB, INSR, PPARA, SRC | 2.07219 |
[BP] GO:0044089 | positive regulation of cellular component biogenesis | ALOX15, ESR1, HSPA1A, KDR, MET, MMP1, SMAD3, SRC, TEK | 2.06151 |
[BP] GO:0008209 | androgen metabolic process | CYP19A1, CYP3A4, ESR1 | 2.02876 |
[BP] GO:0051090 | regulation of DNA binding transcription factor activity | ADORA3, ALK, APP, CYP1B1, ESR1, ESR2, HSPA1A, PIM1 | 2.02031 |
[BP] GO:0045893 | None | APP, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, INSR, MET, MMP12, NR3C1, PPARA, RORC, SMAD3, SRC, TERT | 2.01482 |
[BP] GO:1903508 | None | APP, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, INSR, MET, MMP12, NR3C1, PPARA, RORC, SMAD3, SRC, TERT | 2.01482 |
[BP] GO:1902680 | None | APP, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, INSR, MET, MMP12, NR3C1, PPARA, RORC, SMAD3, SRC, TERT | 2.01219 |
[BP] GO:0043281 | regulation of cysteine-type endopeptidase activity involved in apoptotic process | CSNK2A1, MMP9, PTGS2, SMAD3, SRC, XDH | 2.00977 |
[BP] GO:0051051 | negative regulation of transport | ADORA1, ADRA2A, APP, DRD3, GPR35, HSPA1A, KCNH2, MMP9, PTGS2 | 2.00977 |
[BP] GO:0050880 | None | ADORA1, ADRA2A, EGFR, PTGS2, SLC6A4 | 2.00161 |
[BP] GO:0051253 | None | AURKB, DRD3, ESR1, ESR2, ESRRA, FABP4, HSPA1A, MMP12, NR3C1, PPARA, RORC, SMAD3, SRC, TERT, TRPV1 | 2.00161 |
[CC] GO:0005886 | plasma membrane | ACHE, ADORA1, ADORA3, ADRA2A, ALK, ALOX12, ALOX15, ALPL, APP, AXL, CA12, CA14, CA2, CA4, CA9, CSNK2A1, DRD3, EGFR, ESR1, F10, FLT3, GPR35, IGF1R, INSR, KCNH2, KDR, MET, MMP2, PIK3CA, PIK3CB, PIM1, PTK2, PTPN1, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TERT, TRPV1 | 4.69485 |
[CC] GO:0044444 | cytoplasmic part | ACHE, ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, AOX1, APP, AURKB, CA1, CA2, CA4, CA7, CBR1, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, CYP3A4, DRD3, DUSP3, EGFR, ESR1, ESR2, F10, FABP3, FABP4, FLT3, FUT7, HSD11B1, HSD17B1, HSD17B2, HSPA1A, INSR, KCNH2, KDR, MMP2, MMP9, NQO2, NR3C1, PIK3CA, PIK3CB, PIM1, PTGS1, PTGS2, PTK2, PTPN1, SLC6A4, SMAD3, SRC, TERT, TRPV1, TYR, XDH | 3.77261 |
[CC] GO:0016020 | membrane | ACHE, ADORA1, ADORA3, ADRA2A, ALK, ALOX12, ALOX15, ALOX5, ALPL, APP, AXL, CA12, CA14, CA2, CA4, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, CYP3A4, DRD3, EGFR, ESR1, F10, FLT3, FUT7, GPR35, HSD11B1, HSD17B2, IGF1R, INSR, KCNH2, KDR, MET, MMP2, PIK3CA, PIK3CB, PIM1, PTGS1, PTGS2, PTK2, PTPN1, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TERT, TRPV1, TYR | 3.71242 |
[CC] GO:0044459 | plasma membrane part | ADORA1, ADORA3, ADRA2A, ALK, ALOX15, APP, AXL, CA2, CA4, CA9, DRD3, DUSP3, EGFR, F10, FLT3, GPR35, IGF1R, INSR, KCNH2, KDR, MET, PTGS2, PTK2, SLC6A2, SLC6A4, SRC, TEK, TRPV1 | 3.71169 |
[CC] GO:0045121 | membrane raft | APP, EGFR, INSR, KDR, PTGS2, SLC6A2, SLC6A4, SRC, TEK | 3.46199 |
[CC] GO:0098857 | membrane microdomain | APP, EGFR, INSR, KDR, PTGS2, SLC6A2, SLC6A4, SRC, TEK | 3.44496 |
[CC] GO:0044432 | endoplasmic reticulum part | APP, CES1, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, CYP3A4, EGFR, F10, FLT3, HSD11B1, HSD17B2, PTGS1, PTGS2, PTPN1 | 3.34944 |
[CC] GO:0044425 | membrane part | ACHE, ADORA1, ADORA3, ADRA2A, ALK, ALOX15, ALPL, APP, AXL, CA12, CA14, CA2, CA4, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, CYP3A4, DRD3, DUSP3, EGFR, ESR1, F10, FLT3, FUT7, GPR35, HSD11B1, HSD17B2, IGF1R, INSR, KCNH2, KDR, MET, PIK3CA, PIK3CB, PTGS1, PTGS2, PTK2, PTPN1, SLC6A2, SLC6A4, SRC, TEK, TRPV1, TYR | 3.31245 |
[CC] GO:0031226 | intrinsic component of plasma membrane | ADORA1, ADORA3, ADRA2A, ALK, APP, AXL, CA4, DRD3, F10, FLT3, GPR35, IGF1R, INSR, KDR, MET, SLC6A2, SLC6A4, TEK, TRPV1 | 3.2065 |
[CC] GO:0016323 | basolateral plasma membrane | ADORA1, ADRA2A, CA2, CA4, CA9, EGFR, TEK | 3.02855 |
[CC] GO:0098589 | membrane region | APP, EGFR, INSR, KDR, PTGS2, SLC6A2, SLC6A4, SRC, TEK | 2.93416 |
[CC] GO:0005887 | integral component of plasma membrane | ADORA1, ADORA3, ADRA2A, ALK, APP, AXL, DRD3, FLT3, GPR35, IGF1R, INSR, KDR, MET, SLC6A2, SLC6A4, TEK, TRPV1 | 2.46849 |
[CC] GO:0044464 | cell part | ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, AKR1B10, ALK, ALOX12, ALOX15, ALOX5, ALPL, AOX1, APP, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CBR1, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, CYP3A4, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, FUT7, GPR35, HSD11B1, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KCNH2, KDR, MET, MMP12, MMP2, MMP9, NQO2, NR3C1, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTK2, PTPN1, RORC, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TERT, TRPV1, TYR, XDH | 2.17415 |
[CC] GO:0043227 | membrane-bounded organelle | ACHE, ADORA1, AKR1B1, AKR1B10, ALK, ALOX12, ALPL, AOX1, APP, AURKB, AXL, CA1, CA2, CA4, CBR1, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP3A4, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, HSPA1A, IGF1R, INSR, KDR, MMP12, MMP2, MMP9, NQO2, NR3C1, NUAK1, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTK2, PTPN1, RORC, SMAD3, SRC, TERT, TYR, XDH | 2.0417 |
[CC] GO:0098590 | plasma membrane region | ADORA1, ADRA2A, CA2, CA4, CA9, EGFR, INSR, MET, PTGS2, PTK2, SRC, TEK, TRPV1 | 2.04053 |
[MF] GO:0046914 | transition metal ion binding | ALOX12, ALOX15, ALOX5, AOX1, APP, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, NQO2, NR3C1, PIM1, PPARA, PTPN1, RORC, SMAD3, TYR, XDH | 17.9206 |
[MF] GO:0043167 | ion binding | ACHE, ALK, ALOX12, ALOX15, ALOX5, ALPL, AOX1, APP, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, CYP3A4, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NQO2, NR3C1, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTK2, PTPN1, RORC, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TERT, TRPV1, TYR, XDH | 15.6024 |
[MF] GO:0003824 | catalytic activity | ACHE, ADORA1, AKR1B1, AKR1B10, ALK, ALOX12, ALOX15, ALOX5, ALPL, AOX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CBR1, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, CYP3A4, DUSP3, EGFR, F10, FLT3, FUT7, HSD11B1, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PTGS1, PTGS2, PTK2, PTPN1, SRC, TEK, TERT, TYR, XDH | 13.8046 |
[MF] GO:0004089 | carbonate dehydratase activity | CA1, CA12, CA14, CA2, CA4, CA7, CA9 | 9.94467 |
[MF] GO:0016491 | oxidoreductase activity | AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, AOX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, CYP3A4, HSD11B1, HSD17B1, HSD17B2, NQO2, PTGS1, PTGS2, TYR, XDH | 9.79893 |
[MF] GO:0043169 | cation binding | ACHE, ALOX12, ALOX15, ALOX5, ALPL, AOX1, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, CYP3A4, DRD3, ESR1, ESR2, ESRRA, ESRRB, F10, MMP1, MMP12, MMP2, MMP9, NQO2, NR3C1, NUAK1, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SLC6A2, SLC6A4, SMAD3, TERT, TRPV1, TYR, XDH | 9.54802 |
[MF] GO:0005506 | iron ion binding | ALOX12, ALOX15, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, CYP3A4, XDH | 8.73308 |
[MF] GO:0046872 | metal ion binding | ALOX12, ALOX15, ALOX5, ALPL, AOX1, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, F10, MMP1, MMP12, MMP2, MMP9, NQO2, NR3C1, NUAK1, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SLC6A2, SLC6A4, SMAD3, TERT, TRPV1, TYR, XDH | 8.67742 |
[MF] GO:0004714 | transmembrane receptor protein tyrosine kinase activity | ALK, AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK | 8.61576 |
[MF] GO:0008144 | drug binding | ACHE, ALK, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP3A4, DRD3, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTK2, SLC6A4, SRC, TEK, TRPV1 | 8.61576 |
[MF] GO:0019199 | transmembrane receptor protein kinase activity | ALK, AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK | 7.78092 |
[MF] GO:0008270 | zinc ion binding | CA1, CA12, CA2, CA4, CA7, CA9, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, NQO2, NR3C1, PPARA, PTPN1, RORC, SMAD3 | 7.46047 |
[MF] GO:0020037 | heme binding | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, CYP3A4, PTGS1, PTGS2, SRC | 7.32227 |
[MF] GO:0004713 | protein tyrosine kinase activity | ALK, AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, PTK2, SRC, TEK | 7.12601 |
[MF] GO:0046906 | tetrapyrrole binding | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, CYP3A4, PTGS1, PTGS2, SRC | 7.05406 |
[MF] GO:0016705 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, CYP3A4, PTGS1, PTGS2, TYR | 6.64206 |
[MF] GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4 | 6.63919 |
[MF] GO:0004672 | protein kinase activity | ALK, AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KCNH2, KDR, MET, NUAK1, PIK3CA, PIM1, PTK2, SRC, TEK | 6.5025 |
[MF] GO:0005496 | steroid binding | CYP3A4, ESR1, ESR2, ESRRA, ESRRB, HSD17B1, NR3C1, RORC | 6.23798 |
[MF] GO:0016836 | hydro-lyase activity | CA1, CA12, CA14, CA2, CA4, CA7, CA9 | 6.20318 |
[MF] GO:0016773 | phosphotransferase activity, alcohol group as acceptor | ALK, AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KCNH2, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, PTK2, SRC, TEK | 6.18757 |
[MF] GO:0003707 | steroid hormone receptor activity | ESR1, ESR2, ESRRA, ESRRB, NR3C1, PPARA, RORC | 5.99565 |
[MF] GO:0038023 | signaling receptor activity | ADORA1, ADORA3, ADRA2A, ALK, AXL, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPR35, IGF1R, INSR, KCNH2, KDR, MET, NR3C1, PPARA, RORC, TEK, TRPV1 | 5.92817 |
[MF] GO:0004497 | monooxygenase activity | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, CYP3A4, TYR | 5.92363 |
[MF] GO:0048037 | cofactor binding | AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, CYP3A4, HSD17B1, NQO2, PTGS1, PTGS2, SRC, XDH | 5.64731 |
[MF] GO:0016301 | kinase activity | ALK, AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KCNH2, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, PTK2, SRC, TEK | 5.63765 |
[MF] GO:0004871 | signal transducer activity | ADORA1, ADORA3, ADRA2A, ALK, AXL, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPR35, IGF1R, INSR, KCNH2, KDR, MET, NR3C1, PPARA, PTK2, RORC, SMAD3, TEK, TRPV1 | 5.52541 |
[MF] GO:0016835 | carbon-oxygen lyase activity | CA1, CA12, CA14, CA2, CA4, CA7, CA9 | 5.34164 |
[MF] GO:0016772 | transferase activity, transferring phosphorus-containing groups | ALK, AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KCNH2, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, PTK2, SRC, TEK, TERT | 5.34164 |
[MF] GO:0019825 | oxygen binding | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP3A4 | 5.28127 |
[MF] GO:0070330 | aromatase activity | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 | 5.23903 |
[MF] GO:0098531 | transcription factor activity, direct ligand regulated sequence-specific DNA binding | ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC | 5.09254 |
[MF] GO:0004879 | nuclear receptor activity | ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC | 5.09254 |
[MF] GO:0004872 | receptor activity | ADORA1, ADORA3, ADRA2A, ALK, AXL, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPR35, IGF1R, INSR, KCNH2, KDR, MET, NR3C1, PPARA, RORC, TEK, TRPV1 | 5.07434 |
[MF] GO:0042562 | hormone binding | ACHE, EGFR, HSD17B1, IGF1R, INSR, NQO2, NR3C1 | 5.02156 |
[MF] GO:0043560 | insulin receptor substrate binding | IGF1R, INSR, PIK3CA, PIK3CB | 4.89413 |
[MF] GO:0016614 | oxidoreductase activity, acting on CH-OH group of donors | AKR1B1, AKR1B10, AOX1, CBR1, HSD11B1, HSD17B1, HSD17B2, XDH | 4.85409 |
[MF] GO:0060089 | molecular transducer activity | ADORA1, ADORA3, ADRA2A, ALK, AXL, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPR35, IGF1R, INSR, KCNH2, KDR, MET, NR3C1, PPARA, RORC, TEK, TRPV1 | 4.85409 |
[MF] GO:0044877 | macromolecular complex binding | ACHE, ADORA1, ADRA2A, CSNK2A1, EGFR, ESRRB, FLT3, IGF1R, INSR, KDR, MMP12, MMP9, PIM1, PPARA, PTPN1, SLC6A4, SMAD3, SRC | 4.83167 |
[MF] GO:0008289 | lipid binding | ALOX15, AXL, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, HSD17B1, NR3C1, PPARA, RORC, TRPV1 | 4.79275 |
[MF] GO:0042802 | identical protein binding | ACHE, ADRA2A, ALK, AOX1, APP, CSNK2A1, EGFR, ESR1, ESR2, FLT3, IGF1R, KCNH2, KDR, MET, MMP9, NQO2, PTGS2, SLC6A4, SMAD3, TERT, TRPV1, TYR, XDH | 4.74827 |
[MF] GO:0032403 | protein complex binding | ACHE, ADORA1, ADRA2A, EGFR, ESRRB, FLT3, IGF1R, INSR, KDR, MMP12, MMP9, PPARA, PTPN1, SLC6A4, SMAD3, SRC | 4.69485 |
[MF] GO:0008395 | steroid hydroxylase activity | CYP19A1, CYP1A1, CYP2A6, CYP2C19, CYP3A4 | 4.46297 |
[MF] GO:0097159 | organic cyclic compound binding | ADORA1, ADRA2A, ALK, AOX1, APP, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, CYP3A4, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, NQO2, NR3C1, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTK2, PTPN1, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, TRPV1, XDH | 4.30529 |
[MF] GO:0019899 | enzyme binding | ADRA2A, APP, AURKB, CDC25B, CYP1A1, CYP1A2, CYP2A6, CYP2C19, CYP3A4, DUSP3, EGFR, ESR1, ESR2, ESRRB, HSPA1A, KCNH2, MET, NR3C1, PPARA, PTGS2, PTK2, PTPN1, SLC6A4, SMAD3, SRC, TEK | 4.27103 |
[MF] GO:1901363 | heterocyclic compound binding | ADORA1, ALK, AOX1, APP, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, CYP3A4, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, NQO2, NR3C1, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTK2, PTPN1, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, TRPV1, XDH | 3.55898 |
[MF] GO:0043168 | anion binding | ALK, ALOX15, AOX1, APP, AURKB, AXL, CSNK2A1, EGFR, F10, FABP3, FABP4, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PTK2, SRC, TEK, TRPV1, XDH | 3.55763 |
[MF] GO:0036094 | small molecule binding | ADORA1, ALK, AOX1, AURKB, AXL, CSNK2A1, EGFR, FABP3, FABP4, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PTK2, SRC, TEK, TRPV1, XDH | 3.46199 |
[MF] GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen | ALOX12, ALOX15, ALOX5, PTGS2 | 3.44496 |
[MF] GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen | ALOX12, ALOX15, ALOX5, PTGS2 | 3.39351 |
[MF] GO:0016725 | oxidoreductase activity, acting on CH or CH2 groups | CYP1A2, CYP3A4, XDH | 3.31245 |
[MF] GO:0004716 | signal transducer, downstream of receptor, with protein tyrosine kinase activity | EGFR, INSR, KDR | 3.31245 |
[MF] GO:0009055 | electron transfer activity | AKR1B1, AOX1, CYP19A1, CYP1A2, NQO2, XDH | 3.29754 |
[MF] GO:0140096 | catalytic activity, acting on a protein | ALK, AURKB, AXL, CDC25B, CSNK2A1, DUSP3, EGFR, F10, FLT3, IGF1R, INSR, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIK3CA, PIM1, PTK2, PTPN1, SRC, TEK | 3.23769 |
[MF] GO:0005524 | ATP binding | ALK, AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, PTK2, SRC, TEK, TRPV1 | 3.18581 |
[MF] GO:0016616 | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | AKR1B1, AKR1B10, CBR1, HSD11B1, HSD17B1, HSD17B2 | 3.09706 |
[MF] GO:0000166 | nucleotide binding | ALK, AOX1, AURKB, AXL, CSNK2A1, EGFR, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PTK2, SRC, TEK, TRPV1, XDH | 3.08162 |
[MF] GO:1901265 | nucleoside phosphate binding | ALK, AOX1, AURKB, AXL, CSNK2A1, EGFR, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PTK2, SRC, TEK, TRPV1, XDH | 3.0797 |
[MF] GO:0032559 | adenyl ribonucleotide binding | ALK, AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, PTK2, SRC, TEK, TRPV1 | 3.06327 |
[MF] GO:0016829 | lyase activity | CA1, CA12, CA14, CA2, CA4, CA7, CA9 | 3.0533 |
[MF] GO:0030554 | adenyl nucleotide binding | ALK, AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, PTK2, SRC, TEK, TRPV1 | 3.0328 |
[MF] GO:0004666 | prostaglandin-endoperoxide synthase activity | PTGS1, PTGS2 | 2.93416 |
[MF] GO:0038052 | RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding | ESR1, ESR2 | 2.93416 |
[MF] GO:0047977 | hepoxilin-epoxide hydrolase activity | ALOX12, ALOX15 | 2.93416 |
[MF] GO:0016903 | None | AKR1B1, AKR1B10, AOX1, XDH | 2.6796 |
[MF] GO:0051213 | dioxygenase activity | ALOX12, ALOX15, ALOX5, PTGS1, PTGS2 | 2.64174 |
[MF] GO:0050473 | arachidonate 15-lipoxygenase activity | ALOX15, PTGS2 | 2.53852 |
[MF] GO:0070576 | vitamin D 24-hydroxylase activity | CYP1A1, CYP3A4 | 2.53852 |
[MF] GO:0004052 | arachidonate 12-lipoxygenase activity | ALOX12, ALOX15 | 2.53852 |
[MF] GO:0005330 | None | SLC6A2, SLC6A4 | 2.53852 |
[MF] GO:0051120 | hepoxilin A3 synthase activity | ALOX12, ALOX15 | 2.53852 |
[MF] GO:0047374 | None | CES1, CES2 | 2.53852 |
[MF] GO:0001223 | transcription coactivator binding | ESR1, PPARA, TERT | 2.38877 |
[MF] GO:0031072 | heat shock protein binding | ADORA1, CSNK2A1, HSPA1A, KDR, NR3C1 | 2.37495 |
[MF] GO:0019900 | None | ADRA2A, AURKB, CDC25B, DUSP3, EGFR, ESR1, NR3C1, PTK2, PTPN1, SMAD3, SRC | 2.31597 |
[MF] GO:0034056 | estrogen response element binding | ESR1, ESR2 | 2.28995 |
[MF] GO:0034875 | caffeine oxidase activity | CYP1A2, CYP3A4 | 2.28995 |
[MF] GO:0032795 | None | ADORA1, ADRA2A | 2.28995 |
[MF] GO:0051425 | None | APP, INSR | 2.28995 |
[MF] GO:0033695 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor | CYP1A2, CYP3A4 | 2.28995 |
[MF] GO:0042803 | protein homodimerization activity | ACHE, ADRA2A, AOX1, FLT3, KCNH2, NQO2, PTGS2, SLC6A4, SMAD3, TERT, TYR, XDH | 2.25534 |
[MF] GO:0035639 | purine ribonucleoside triphosphate binding | ALK, AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, PTK2, SRC, TEK, TRPV1 | 2.17415 |
[MF] GO:0005518 | collagen binding | ACHE, MMP12, MMP9, SMAD3 | 2.17368 |
[MF] GO:0019901 | None | ADRA2A, CDC25B, DUSP3, EGFR, ESR1, NR3C1, PTK2, PTPN1, SMAD3, SRC | 2.15565 |
[MF] GO:0005057 | signal transducer activity, downstream of receptor | ALK, EGFR, INSR, KDR, SMAD3 | 2.12277 |
[MF] GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity | EGFR, MET, PIK3CA, PIK3CB | 2.10885 |
[MF] GO:0101020 | estrogen 16-alpha-hydroxylase activity | CYP1A1, CYP3A4 | 2.10885 |
[MF] GO:0030284 | estrogen receptor activity | ESR1, ESR2 | 2.10885 |
[MF] GO:0043559 | insulin binding | IGF1R, INSR | 2.10885 |
[MF] GO:0032555 | purine ribonucleotide binding | ALK, AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, PTK2, SRC, TEK, TRPV1 | 2.07037 |
[MF] GO:0033764 | steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | HSD11B1, HSD17B1, HSD17B2 | 2.06792 |
[MF] GO:0099600 | transmembrane receptor activity | ADORA1, ADORA3, ADRA2A, ALK, AXL, DRD3, EGFR, FLT3, GPR35, IGF1R, INSR, KDR, MET, TEK, TRPV1 | 2.05495 |
[MF] GO:0004888 | transmembrane signaling receptor activity | ADORA1, ADORA3, ADRA2A, ALK, AXL, DRD3, EGFR, FLT3, GPR35, IGF1R, INSR, KDR, MET, TEK, TRPV1 | 2.05495 |
[MF] GO:0052813 | phosphatidylinositol bisphosphate kinase activity | EGFR, MET, PIK3CA, PIK3CB | 2.05291 |
[MF] GO:0017076 | purine nucleotide binding | ALK, AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, PTK2, SRC, TEK, TRPV1 | 2.04053 |
[MF] GO:0046983 | protein dimerization activity | ACHE, ADORA1, ADRA2A, AOX1, AXL, EGFR, FLT3, KCNH2, NQO2, PTGS2, SLC6A4, SMAD3, TERT, TYR, XDH | 2.04053 |
[MF] GO:0032553 | ribonucleotide binding | ALK, AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, PTK2, SRC, TEK, TRPV1 | 2.0338 |
[MF] GO:0019838 | growth factor binding | EGFR, IGF1R, INSR, KDR, TEK | 2.02619 |
KEGG Pathway ID | Enriched Genes | Log10 Adjusted P-value |
---|---|---|
Ovarian steroidogenesis_Homo sapiens_hsa04913 | ALOX5, INSR, HSD17B1, HSD17B2, CYP1A1, CYP1B1, PTGS2, CYP19A1, IGF1R | 10.4936 |
Nitrogen metabolism_Homo sapiens_hsa00910 | CA12, CA1, CA2, CA4, CA7, CA9, CA14 | 10.4936 |
Metabolic pathways_Homo sapiens_hsa01100 | CBR1, ALOX15, AKR1B1, ALOX12, PTGS2, TYR, CYP3A4, CYP2C19, CYP19A1, PTGS1, HSD11B1, CYP2A6, FUT7, AKR1B10, ALOX5, HSD17B1, HSD17B2, CYP1A2, CYP1A1, AOX1, ALPL, XDH, CES1 | 7.9776 |
Estrogen signaling pathway_Homo sapiens_hsa04915 | PIK3CA, SRC, MMP2, PIK3CB, MMP9, ESR1, EGFR, ESR2, HSPA1A | 8.1212 |
Proteoglycans in cancer_Homo sapiens_hsa05205 | PIK3CA, SRC, MMP2, KDR, PIK3CB, MMP9, MET, ESR1, EGFR, PTK2, IGF1R | 7.9144 |
Chemical carcinogenesis_Homo sapiens_hsa05204 | HSD11B1, CBR1, CYP2A6, CYP1A2, CYP1A1, CYP1B1, PTGS2, CYP3A4, CYP2C19 | 8.6469 |
Steroid hormone biosynthesis_Homo sapiens_hsa00140 | HSD11B1, HSD17B1, HSD17B2, CYP1A2, CYP1A1, CYP1B1, CYP3A4, CYP19A1 | 8.4861 |
Adherens junction_Homo sapiens_hsa04520 | PTPN1, SMAD3, CSNK2A1, SRC, INSR, MET, EGFR, IGF1R | 7.9144 |
Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | FABP4, PIK3CA, INSR, ADORA1, PIK3CB, PTGS2, PTGS1 | 7.3224 |
Arachidonic acid metabolism_Homo sapiens_hsa00590 | CBR1, ALOX5, ALOX15, ALOX12, PTGS2, CYP2C19, PTGS1 | 7.0501 |
Pathways in cancer_Homo sapiens_hsa05200 | SMAD3, PIK3CA, FLT3, MMP1, MMP2, PIK3CB, PTGS2, MMP9, MET, EGFR, PTK2, IGF1R | 6.1004 |
Serotonergic synapse_Homo sapiens_hsa04726 | APP, ALOX5, ALOX15, ALOX12, PTGS2, CYP2C19, PTGS1, SLC6A4 | 6.6245 |
Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | HSD11B1, CBR1, CYP2A6, CYP1A2, CYP1A1, CYP1B1, CYP3A4 | 6.6245 |
Rap1 signaling pathway_Homo sapiens_hsa04015 | PIK3CA, SRC, INSR, KDR, TEK, PIK3CB, MET, EGFR, IGF1R | 5.7111 |
VEGF signaling pathway_Homo sapiens_hsa04370 | PIK3CA, SRC, KDR, PIK3CB, PTGS2, PTK2 | 5.7172 |
Focal adhesion_Homo sapiens_hsa04510 | PIK3CA, SRC, KDR, PIK3CB, MET, EGFR, PTK2, IGF1R | 4.8726 |
Ras signaling pathway_Homo sapiens_hsa04014 | PIK3CA, INSR, KDR, TEK, PIK3CB, MET, EGFR, IGF1R | 4.5391 |
HIF-1 signaling pathway_Homo sapiens_hsa04066 | PIK3CA, INSR, TEK, PIK3CB, EGFR, IGF1R | 4.5391 |
PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | PIK3CA, INSR, KDR, TEK, PIK3CB, MET, EGFR, PTK2, IGF1R | 4.2451 |
Bladder cancer_Homo sapiens_hsa05219 | SRC, MMP1, MMP2, MMP9, EGFR | 5.2238 |
Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | PIK3CA, INSR, PIK3CB, IGF1R, HSPA1A | 4.3791 |
Drug metabolism - other enzymes_Homo sapiens_hsa00983 | CYP2A6, CYP3A4, XDH, CES2, CES1 | 4.9931 |
Central carbon metabolism in cancer_Homo sapiens_hsa05230 | PIK3CA, FLT3, PIK3CB, MET, EGFR | 4.3169 |
Retinol metabolism_Homo sapiens_hsa00830 | CYP2A6, CYP1A2, CYP1A1, AOX1, CYP3A4 | 4.3643 |
Melanoma_Homo sapiens_hsa05218 | PIK3CA, PIK3CB, MET, EGFR, IGF1R | 4.2418 |
MicroRNAs in cancer_Homo sapiens_hsa05206 | PIK3CA, PIM1, CYP1B1, PTGS2, MMP9, MET, EGFR, CDC25B | 3.8952 |
Prolactin signaling pathway_Homo sapiens_hsa04917 | PIK3CA, SRC, PIK3CB, ESR1, ESR2 | 4.2272 |
FoxO signaling pathway_Homo sapiens_hsa04068 | SMAD3, PIK3CA, INSR, PIK3CB, EGFR, IGF1R | 4.0712 |
Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | CYP2A6, CYP1A2, AOX1, CYP3A4, CYP2C19 | 4.2708 |
AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | SMAD3, PIK3CA, MMP2, PIM1, PIK3CB | 3.608 |
Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | PIK3CA, SRC, ALOX12, PIK3CB, TRPV1 | 3.6584 |
cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | PIK3CA, ADORA3, INSR, ADORA1, PIK3CB, ADRA2A | 3.5919 |
Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | PIK3CA, SRC, PIK3CB, MET, PTK2 | 4.0715 |
ErbB signaling pathway_Homo sapiens_hsa04012 | PIK3CA, SRC, PIK3CB, EGFR, PTK2 | 3.8952 |
Endocytosis_Homo sapiens_hsa04144 | SMAD3, SRC, KDR, MET, EGFR, IGF1R, HSPA1A | 3.4766 |
Insulin resistance_Homo sapiens_hsa04931 | PTPN1, PIK3CA, INSR, PIK3CB, PPARA | 3.4849 |
Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | GPR35, ADORA3, ADORA1, TRPV1, NR3C1, DRD3, ADRA2A | 3.316 |
Leukocyte transendothelial migration_Homo sapiens_hsa04670 | PIK3CA, MMP2, PIK3CB, MMP9, PTK2 | 3.3541 |
Hepatitis B_Homo sapiens_hsa05161 | SMAD3, PIK3CA, SRC, PIK3CB, MMP9 | 2.9809 |
Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | SMAD3, PIK3CA, ESRRB, PIK3CB, IGF1R | 3.0273 |
Oxytocin signaling pathway_Homo sapiens_hsa04921 | PIK3CA, SRC, PIK3CB, PTGS2, EGFR | 2.841 |
Non-small cell lung cancer_Homo sapiens_hsa05223 | ALK, PIK3CA, PIK3CB, EGFR | 3.4884 |
Linoleic acid metabolism_Homo sapiens_hsa00591 | ALOX15, CYP1A2, CYP3A4, CYP2C19 | 4.4043 |
Glioma_Homo sapiens_hsa05214 | PIK3CA, PIK3CB, EGFR, IGF1R | 3.2984 |
Acute myeloid leukemia_Homo sapiens_hsa05221 | PIK3CA, FLT3, PIM1, PIK3CB | 3.4803 |
Prostate cancer_Homo sapiens_hsa05215 | PIK3CA, PIK3CB, EGFR, IGF1R | 2.8374 |
Pancreatic cancer_Homo sapiens_hsa05212 | SMAD3, PIK3CA, PIK3CB, EGFR | 3.2823 |
Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | FLT3, MMP9, MET, PTK2, IGF1R | 2.626 |
Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | PIK3CA, PIK3CB, CDC25B, IGF1R | 2.704 |
Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | PIK3CA, INSR, PIK3CB, IGF1R | 2.7642 |
Small cell lung cancer_Homo sapiens_hsa05222 | PIK3CA, PIK3CB, PTGS2, PTK2 | 2.8768 |
TNF signaling pathway_Homo sapiens_hsa04668 | PIK3CA, PIK3CB, PTGS2, MMP9 | 2.5399 |
Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | PIK3CA, SRC, PIK3CB, EGFR, PTK2 | 2.3586 |
Tryptophan metabolism_Homo sapiens_hsa00380 | CYP1A2, CYP1A1, AOX1, CYP1B1 | 3.9965 |
Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | PIK3CA, SRC, PIK3CB, ESR1 | 2.4492 |
Platelet activation_Homo sapiens_hsa04611 | PIK3CA, SRC, PIK3CB, PTGS1 | 2.4101 |
Toxoplasmosis_Homo sapiens_hsa05145 | PIK3CA, ALOX5, PIK3CB, HSPA1A | 2.4492 |
PPAR signaling pathway_Homo sapiens_hsa03320 | FABP3, FABP4, MMP1, PPARA | 3.2169 |
Sphingolipid signaling pathway_Homo sapiens_hsa04071 | PIK3CA, ADORA3, ADORA1, PIK3CB | 2.4293 |
AMPK signaling pathway_Homo sapiens_hsa04152 | PIK3CA, INSR, PIK3CB, IGF1R | 2.391 |
Measles_Homo sapiens_hsa05162 | CSNK2A1, PIK3CA, PIK3CB, HSPA1A | 2.2713 |
Hepatitis C_Homo sapiens_hsa05160 | PIK3CA, PIK3CB, PPARA, EGFR | 2.3 |
Phospholipase D signaling pathway_Homo sapiens_hsa04072 | PIK3CA, INSR, PIK3CB, EGFR | 2.2067 |
Insulin signaling pathway_Homo sapiens_hsa04910 | PTPN1, PIK3CA, INSR, PIK3CB | 2.2497 |
Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | PIK3CA, INSR, PIK3CB, PPARA | 2.1447 |
Jak-STAT signaling pathway_Homo sapiens_hsa04630 | PIK3CA, PIM1, AOX1, PIK3CB | 2.0862 |
Chemokine signaling pathway_Homo sapiens_hsa04062 | PIK3CA, SRC, PIK3CB, PTK2 | 1.8462 |
Epstein-Barr virus infection_Homo sapiens_hsa05169 | CSNK2A1, PIK3CA, PIK3CB, HSPA1A | 1.768 |
cAMP signaling pathway_Homo sapiens_hsa04024 | PIK3CA, ADORA1, PIK3CB, PPARA | 1.7799 |
MAPK signaling pathway_Homo sapiens_hsa04010 | DUSP3, EGFR, CDC25B, HSPA1A | 1.45 |
HTLV-I infection_Homo sapiens_hsa05166 | SMAD3, PIK3CA, TERT, PIK3CB | 1.4383 |
Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | FLT3, KDR, MET, EGFR | 1.4055 |
Herpes simplex infection_Homo sapiens_hsa05168 | CSNK2A1 | 0.2761 |
Purine metabolism_Homo sapiens_hsa00230 | XDH | 0.2824 |
Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | HSPA1A | 0.2918 |
Calcium signaling pathway_Homo sapiens_hsa04020 | EGFR | 0.2813 |
Tuberculosis_Homo sapiens_hsa05152 | SRC | 0.2818 |
GnRH signaling pathway_Homo sapiens_hsa04912 | SRC, MMP2, EGFR | 1.9027 |
Alzheimer's disease_Homo sapiens_hsa05010 | APP | 0.2918 |
Hippo signaling pathway_Homo sapiens_hsa04390 | SMAD3 | 0.3169 |
Choline metabolism in cancer_Homo sapiens_hsa05231 | PIK3CA, PIK3CB, EGFR | 1.8055 |
Spliceosome_Homo sapiens_hsa03040 | HSPA1A | 0.3565 |
Amoebiasis_Homo sapiens_hsa05146 | PIK3CA, PIK3CB, PTK2 | 1.8119 |
Viral carcinogenesis_Homo sapiens_hsa05203 | PIK3CA, SRC, PIK3CB | 1.1057 |
Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | SMAD3, PIK3CA, PIK3CB | 1.7799 |
Cholinergic synapse_Homo sapiens_hsa04725 | ACHE, PIK3CA, PIK3CB | 1.7249 |
Dopaminergic synapse_Homo sapiens_hsa04728 | DRD3 | 0.3661 |
Oocyte meiosis_Homo sapiens_hsa04114 | IGF1R | 0.3791 |
Influenza A_Homo sapiens_hsa05164 | PIK3CA, PIK3CB, HSPA1A | 1.263 |
Chronic myeloid leukemia_Homo sapiens_hsa05220 | SMAD3, PIK3CA, PIK3CB | 2.1473 |
Apoptosis_Homo sapiens_hsa04210 | PIK3CA, PIK3CB | 0.8348 |
Melanogenesis_Homo sapiens_hsa04916 | TYR | 0.4441 |
Glucagon signaling pathway_Homo sapiens_hsa04922 | PPARA | 0.4441 |
Osteoclast differentiation_Homo sapiens_hsa04380 | PIK3CA, PIK3CB | 0.8573 |
Tight junction_Homo sapiens_hsa04530 | CSNK2A1, SRC | 0.8353 |
Neurotrophin signaling pathway_Homo sapiens_hsa04722 | PIK3CA, PIK3CB | 0.9122 |
Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | PIK3CA, PIK3CB | 0.8529 |
Glycerophospholipid metabolism_Homo sapiens_hsa00564 | ACHE | 0.4538 |
Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | PTGS2 | 0.4441 |
Cell cycle_Homo sapiens_hsa04110 | SMAD3, CDC25B | 0.8921 |
Pancreatic secretion_Homo sapiens_hsa04972 | CA2 | 0.4531 |
Axon guidance_Homo sapiens_hsa04360 | MET, PTK2 | 0.8784 |
Wnt signaling pathway_Homo sapiens_hsa04310 | SMAD3, CSNK2A1 | 0.8312 |
Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | PIK3CA, PIK3CB | 0.8122 |
Morphine addiction_Homo sapiens_hsa05032 | ADORA1 | 0.4662 |
Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | PIK3CA, PIK3CB | 1.001 |
Hematopoietic cell lineage_Homo sapiens_hsa04640 | FLT3 | 0.4722 |
GABAergic synapse_Homo sapiens_hsa04727 | SRC | 0.4722 |
TGF-beta signaling pathway_Homo sapiens_hsa04350 | SMAD3 | 0.4829 |
Renal cell carcinoma_Homo sapiens_hsa05211 | PIK3CA, PIK3CB, MET | 2.2497 |
T cell receptor signaling pathway_Homo sapiens_hsa04660 | PIK3CA, PIK3CB | 1.0114 |
Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | CSNK2A1 | 0.4712 |
Endometrial cancer_Homo sapiens_hsa05213 | PIK3CA, PIK3CB, EGFR | 2.4763 |
Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | PIK3CA, PIK3CB | 1.0845 |
Peroxisome_Homo sapiens_hsa04146 | XDH | 0.4841 |
Colorectal cancer_Homo sapiens_hsa05210 | SMAD3, PIK3CA, PIK3CB | 2.305 |
Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | PIK3CA, PIK3CB | 1.0526 |
Complement and coagulation cascades_Homo sapiens_hsa04610 | F10 | 0.4991 |
Rheumatoid arthritis_Homo sapiens_hsa05323 | MMP1, TEK | 1.1015 |
Antigen processing and presentation_Homo sapiens_hsa04612 | HSPA1A | 0.5054 |
Leishmaniasis_Homo sapiens_hsa05140 | PTGS2 | 0.5188 |
NF-kappa B signaling pathway_Homo sapiens_hsa04064 | CSNK2A1, PTGS2 | 1.0845 |
Gastric acid secretion_Homo sapiens_hsa04971 | CA2 | 0.517 |
Gap junction_Homo sapiens_hsa04540 | SRC, EGFR | 1.1104 |
Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | SRC, MET, EGFR | 2.2226 |
Adipocytokine signaling pathway_Homo sapiens_hsa04920 | PPARA | 0.5314 |
Renin secretion_Homo sapiens_hsa04924 | ADORA1 | 0.5586 |
Shigellosis_Homo sapiens_hsa05131 | SRC | 0.5561 |
B cell receptor signaling pathway_Homo sapiens_hsa04662 | PIK3CA, PIK3CB | 1.2527 |
Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | PIK3CA, PIK3CB | 1.2914 |
Long-term depression_Homo sapiens_hsa04730 | IGF1R | 0.58 |
Type II diabetes mellitus_Homo sapiens_hsa04930 | PIK3CA, INSR, PIK3CB | 2.5624 |
Inositol phosphate metabolism_Homo sapiens_hsa00562 | PIK3CA, PIK3CB | 1.2659 |
Bile secretion_Homo sapiens_hsa04976 | CA2, CYP3A4 | 1.2659 |
Legionellosis_Homo sapiens_hsa05134 | HSPA1A | 0.6103 |
mTOR signaling pathway_Homo sapiens_hsa04150 | PIK3CA, PIK3CB | 1.3828 |
Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | SMAD3, RORC | 1.3229 |
Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | PIK3CA, INSR, PIK3CB | 2.7959 |
Glycerolipid metabolism_Homo sapiens_hsa00561 | AKR1B10, AKR1B1 | 1.3886 |
Malaria_Homo sapiens_hsa05144 | MET | 0.6521 |
Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | ESR1 | 0.6615 |
Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | AOX1 | 0.6568 |
Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | PIK3CA, PIK3CB | 1.5896 |
Prion diseases_Homo sapiens_hsa05020 | HSPA1A | 0.776 |
Dorso-ventral axis formation_Homo sapiens_hsa04320 | EGFR | 0.8529 |
Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | FUT7 | 0.8182 |
Galactose metabolism_Homo sapiens_hsa00052 | AKR1B10, AKR1B1 | 1.8716 |
Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | AOX1 | 0.8348 |
Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | FUT7 | 0.8573 |
Tyrosine metabolism_Homo sapiens_hsa00350 | AOX1, TYR | 1.7791 |
Fructose and mannose metabolism_Homo sapiens_hsa00051 | AKR1B10, AKR1B1 | 1.8283 |
Circadian rhythm_Homo sapiens_hsa04710 | RORC | 0.828 |
Collecting duct acid secretion_Homo sapiens_hsa04966 | CA2 | 0.8529 |
Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | AKR1B10, AKR1B1 | 1.7657 |
Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | CA2, CA4 | 2.0862 |
Caffeine metabolism_Homo sapiens_hsa00232 | CYP2A6, CYP1A2, XDH | 5.2238 |
Folate biosynthesis_Homo sapiens_hsa00790 | ALPL | 1.0843 |
Vitamin B6 metabolism_Homo sapiens_hsa00750 | AOX1 | 1.3886 |